[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,879,925,1030,1125,1231,1289,1447,1604],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":863,"citationCount":26,"citationInfo":26,"publishDate":877,"publishYear":878,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"02a8e3ee-d8d6-41d8-86f5-5144853a9b0a","2024-01-11T06:50:21.574+00:00","2024-12-12T00:55:43.470+00:00",[],"Estrategia-de-diagn%C3%B3stico-prenatal-y-tratamiento-de-las-enfermedades-relacionadas-con-los-embarazos-m%C3%BAltiples",{"references":780,"title":782,"doi":784},{"VOID":781},"Evans, 2010, Screening and testing in multiples, Clin Lab Med, 30, 643, 10.1016\u002Fj.cll.2010.05.005\nVayssiere, 2010, Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF), Eur J Obstet Gynecol Reprod Biol, 156, 12, 10.1016\u002Fj.ejogrb.2010.12.045\nCuckle, 1998, Down's syndrome screening in twins, J Med Screen, 5, 3, 10.1136\u002Fjms.5.1.3\nSebire, 1997, The prevalence and consequences of missed abortion in twin pregnancies at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, 104, 847, 10.1111\u002Fj.1471-0528.1997.tb12033.x\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation, Br J Obstet Gynaecol, 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nOdibo, 2003, Screening for aneuploidy in twins and higher-order multiples: is first-trimester nuchal translucency the solution?, Obstet Gynecol Surv, 58, 609, 10.1097\u002F01.OGX.0000082369.30519.A8\nGlinianaia, 2008, Congenital anomalies in twins: a register-based study, Hum Reprod, 23, 1306, 10.1093\u002Fhumrep\u002Fden104\nBryan, 1987, Congenital anomalies in twins, Baillieres Clin Obstet Gynaecol, 1, 697, 10.1016\u002FS0950-3552(87)80012-3\nLewi, 2008, The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study, Am J Obstet Gynecol, 199, 514, 10.1016\u002Fj.ajog.2008.03.050\nSepulveda, 2005, Discordant lower urinary tract obstruction in early twin gestations: management and outcome, Obstet Gynecol, 106, 797, 10.1097\u002F01.AOG.0000175833.65983.ee\nWeber, 2010, Genetics and developmental pathology of twinning, Semin Fetal Neonatal Med, 15, 313, 10.1016\u002Fj.siny.2010.06.002\nWeisz, 2004, Tailored management of twin reversed arterial perfusion (trap) sequence, Ultrasound Obstet Gynecol, 23, 451, 10.1002\u002Fuog.1040\nNakata, 2008, Fetoscopic laser photocoagulation of placental communicating vessels for twin-reversed arterial perfusion sequence, J Obstet Gynaecol Res, 34, 649, 10.1111\u002Fj.1447-0756.2008.00901.x\nDiehl, 2007, Selective cord coagulation in acardiac twins, Semin Fetal Neonatal Med, 12, 458, 10.1016\u002Fj.siny.2007.06.008\nRossi, 2008, Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome: a meta-analysis and review of literature, Am J Obstet Gynecol, 198, 147, 10.1016\u002Fj.ajog.2007.09.043\nRoman, 2010, Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation, Ultrasound Obstet Gynecol, 36, 37, 10.1002\u002Fuog.7567\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par foeticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007\nYamamoto, 2005, Incidence and impact of perioperative complications in 175 fetoscopy-guided laser coagulations of chorionic plate anastomoses in fetofetal transfusion syndrome before 26 weeks of gestation, Am J Obstet Gynecol, 193, 1110, 10.1016\u002Fj.ajog.2005.07.003\nQuintero, 1999, Staging of twin-twin transfusion syndrome, J Perinatol, 19, 550, 10.1038\u002Fsj.jp.7200292\nQuintero, 2003, Stage-based treatment of twin-twin transfusion syndrome, Am J Obstet Gynecol, 188, 1333, 10.1067\u002Fmob.2003.292\nHuber, 2006, Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation, Obstet Gynecol, 108, 333, 10.1097\u002F01.AOG.0000225945.17022.6b\nHarkness, 2005, Twin-twin transfusion syndrome: where do we go from here?, Semin Perinatol, 29, 296, 10.1053\u002Fj.semperi.2005.10.001\nRoberts, 2008, Interventions for twin-twin transfusion syndrome: a Cochrane review, Ultrasound Obstet Gynecol, 31, 701, 10.1002\u002Fuog.5328\nDelabaere, 2011, Résultats favorables d’une équipe émergente dans le traitement du syndrome transfuseur–transfusé par photocoagulation-laser, Gynecol Obstet Fertil, 39, 482, 10.1016\u002Fj.gyobfe.2011.02.016\nSlaghekke, 2010, Twin anemia-polycythemia sequence: diagnostic criteria, classification, perinatal management and outcome, Fetal Diagn Ther, 27, 181, 10.1159\u002F000304512\nLopriore, 2008, Fetal and neonatal haematological complications in monochorionic twins, Semin Fetal Neonatal Med, 13, 231, 10.1016\u002Fj.siny.2008.02.002\nLopriore, 2009, Residual anastomoses in twin-to-twin transfusion syndrome treated with selective fetoscopic laser surgery: localization, size, and consequences, Am J Obstet Gynecol, 201, 66, 10.1016\u002Fj.ajog.2009.01.010\nRobyr, 2006, Prevalence and management of late fetal complications following successful selective laser coagulation of chorionic plate anastomoses in twin-to-twin transfusion syndrome, Am J Obstet Gynecol, 194, 796, 10.1016\u002Fj.ajog.2005.08.069\nLewi, 2006, Pregnancy and infant outcome of 80 consecutive cord coagulations in complicated monochorionic multiple pregnancies, Am J Obstet Gynecol, 194, 782, 10.1016\u002Fj.ajog.2005.09.013\nHabli, 2009, Incidence of complications in twin-twin transfusion syndrome after selective fetoscopic laser photocoagulation: a single-center experience, Am J Obstet Gynecol, 201, 417, 10.1016\u002Fj.ajog.2009.07.046\nRussell, 2007, Intrauterine growth restriction in monochorionic twins, Semin Fetal Neonatal Med, 12, 439, 10.1016\u002Fj.siny.2007.06.004\nChang, 2009, Clinical outcome and placental territory ratio of monochorionic twin pregnancies and selective intrauterine growth restriction with different types of umbilical artery Doppler, Prenat Diagn, 29, 253, 10.1002\u002Fpd.2193\nDenbow, 2000, Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome, Am J Obstet Gynecol, 182, 417, 10.1016\u002FS0002-9378(00)70233-X\nLeduc, 2005, Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation, Am J Obstet Gynecol, 193, 1670, 10.1016\u002Fj.ajog.2005.04.007\nAcosta-Rojas, 2007, Twin chorionicity and the risk of adverse perinatal outcome, Int J Gynaecol Obstet, 96, 98, 10.1016\u002Fj.ijgo.2006.11.002\nGratacos, 2004, Prevalence of neurological damage in monochorionic twins with selective intrauterine growth restriction and intermittent absent or reversed end-diastolic umbilical artery flow, Ultrasound Obstet Gynecol, 24, 159, 10.1002\u002Fuog.1105\nIshii, 2009, Perinatal outcome of monochorionic twins with selective intrauterine growth restriction and different types of umbilical artery Doppler under expectant management, Fetal Diagn Ther, 26, 157, 10.1159\u002F000253880\nValsky, 2010, Selective intrauterine growth restriction in monochorionic twins: pathophysiology, diagnostic approach and management dilemmas, Semin Fetal Neonatal Med, 15, 342, 10.1016\u002Fj.siny.2010.07.002\nGratacos, 2007, A classification system for selective intrauterine growth restriction in monochorionic pregnancies according to umbilical artery Doppler flow in the smaller twin, Ultrasound Obstet Gynecol, 30, 28, 10.1002\u002Fuog.4046\nAxt, 1999, Maternal and neonatal outcome of twin pregnancies complicated by single fetal death, J Perinat Med, 27, 221, 10.1515\u002FJPM.1999.031\nLee, 2008, Twin chorionicity and the risk of stillbirth, Obstet Gynecol, 111, 301, 10.1097\u002FAOG.0b013e318160d65d\nOng, 2006, Prognosis for the co-twin following single-twin death: a systematic review, Bjog, 113, 992, 10.1111\u002Fj.1471-0528.2006.01027.x\nWoo, 2000, Single foetal death in twin pregnancies: review of the maternal and neonatal outcomes and management, Hong Kong Med J, 6, 293\nvan Heteren, 1998, Risk for surviving twin after fetal death of co-twin in twin-twin transfusion syndrome, Obstet Gynecol, 92, 215, 10.1016\u002FS0029-7844(98)00159-8\nBejar, 1990, Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations, Am J Obstet Gynecol, 162, 1230, 10.1016\u002F0002-9378(90)90024-2\nNicolini, 1999, Single intrauterine death in monochorionic twin pregnancies, Ultrasound Obstet Gynecol, 14, 297, 10.1046\u002Fj.1469-0705.1999.14050297.x\nSchinzel, 1979, Monozygotic twinning and structural defects, J Pediatr, 95, 921, 10.1016\u002FS0022-3476(79)80278-4\nMoore, 1969, Intrauterine disseminated intravascular coagulation: a syndrome of multiple pregnancy with a dead twin fetus, J Pediatr, 74, 523, 10.1016\u002FS0022-3476(69)80034-X\nWeisz, 2005, Invasive diagnostic procedures in twin pregnancies, Prenat Diagn, 25, 751, 10.1002\u002Fpd.1263\nNieuwint, 1999, “Identical” twins with discordant karyotypes, Prenat Diagn, 19, 72, 10.1002\u002F(SICI)1097-0223(199901)19:1\u003C72::AID-PD465>3.0.CO;2-V\nToth-Pal, 2004, Genetic amniocentesis in multiple pregnancy, Fetal Diagn Ther, 19, 138, 10.1159\u002F000075138\nMujezinovic, 2007, Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review, Obstet Gynecol, 110, 687, 10.1097\u002F01.AOG.0000278820.54029.e3\nDommergues, 1991, Embryo reduction in multifetal pregnancies after infertility therapy: obstetrical risks and perinatal benefits are related to operative strategy, Fertil Steril, 55, 805, 10.1016\u002FS0015-0282(16)54252-6\nEvans, 1994, Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases, Am J Obstet Gynecol, 170, 902, 10.1016\u002FS0002-9378(94)70306-X\nWapner, 1990, Selective reduction of multifetal pregnancies, Lancet, 335, 90, 10.1016\u002F0140-6736(90)90550-O\nSentilhes, 2008, Multifetal pregnancy reduction: indications, technical aspects and psychological impact, Presse Med, 37, 295, 10.1016\u002Fj.lpm.2007.05.016\nSenat, 2002, Funipuncture for fetocide in late termination of pregnancy, Prenat Diagn, 22, 354, 10.1002\u002Fpd.290\nBhide, 2002, Comparison of feticide carried out by cordocentesis versus cardiac puncture, Ultrasound Obstet Gynecol, 20, 230, 10.1046\u002Fj.1469-0705.2002.00797.x\nSenat, 2003, The use of lidocaine for fetocide in late termination of pregnancy, Bjog, 110, 296, 10.1046\u002Fj.1471-0528.2003.02217.x\nNielsen, 1991, Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study, Reg Anesth, 16, 28\nRossi, 2009, Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, Am J Obstet Gynecol, 200, 123, 10.1016\u002Fj.ajog.2008.08.039\nDelabaere, 2013, Suivi pédiatrique de 30 grossesses gémellaires monochoriales consécutives traitées par fœticide sélectif, Gynecol Obstet Fertil, 41, 85, 10.1016\u002Fj.gyobfe.2012.12.007",{"ES":783},"Estrategia de diagnóstico prenatal y tratamiento de las enfermedades relacionadas con los embarazos múltiples",{"VOID":785},"10.1016\u002Fs1283-081x(13)65365-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X13653655",[788,803,815,827,839,851],{"id":789,"sortIndex":36,"researcher":26,"roles":790,"affiliations":791,"properties":800},"a6572e51-5aa5-4115-a749-b8be236a9f71",[696],[792],{"id":26,"sortIndex":36,"affiliation":793,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":796,"slug":26,"properties":797,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3677a859-5b95-42dd-85d4-27d0c50a01c8","2024-01-11T06:50:21.681+00:00",[],{"title":798},{"VI":799},"Pôle gynéco-obstétrique-reproduction humaine, Centre hospitalier universitaire de Clermont-Ferrand, Centre hospitalier universitaire Estaing, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France",{"title":801},{"VI":802},"A. Delabaere",{"id":804,"sortIndex":111,"researcher":26,"roles":805,"affiliations":806,"properties":812},"96b7792f-c31e-4cf1-a02e-3f39936930c8",[696],[807],{"id":26,"sortIndex":36,"affiliation":808,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":809,"slug":26,"properties":810,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":811},{"VI":799},{"title":813},{"VI":814},"D. Lémery",{"id":816,"sortIndex":114,"researcher":26,"roles":817,"affiliations":818,"properties":824},"caa7839d-08a4-44d3-8caf-161f5aa1e31b",[696],[819],{"id":26,"sortIndex":36,"affiliation":820,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":821,"slug":26,"properties":822,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":823},{"VI":799},{"title":825},{"VI":826},"F. Desvignes",{"id":828,"sortIndex":59,"researcher":26,"roles":829,"affiliations":830,"properties":836},"ded6f25d-5999-4755-a55e-a0f662dd5de9",[696],[831],{"id":26,"sortIndex":36,"affiliation":832,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":833,"slug":26,"properties":834,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":835},{"VI":799},{"title":837},{"VI":838},"H. Laurichesse-Delmas",{"id":840,"sortIndex":115,"researcher":26,"roles":841,"affiliations":842,"properties":848},"4755ec38-4344-4dc0-a5a3-5afcef6f72f5",[696],[843],{"id":26,"sortIndex":36,"affiliation":844,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":845,"slug":26,"properties":846,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":847},{"VI":799},{"title":849},{"VI":850},"S. Curinier",{"id":852,"sortIndex":162,"researcher":26,"roles":853,"affiliations":854,"properties":860},"444c2686-0290-4423-852c-e0810bccc815",[696],[855],{"id":26,"sortIndex":36,"affiliation":856,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":857,"slug":26,"properties":858,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":859},{"VI":799},{"title":861},{"VI":862},"D. Gallot",{"url":786,"publisher":864,"properties":872},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":865,"slug":662,"properties":866,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":869,"manageAffiliations":870,"indexDatabases":871,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":867,"title":868},{"VOID":665},{"EN":667},[],[],[],{"volume":873,"pages":875},{"VOID":874},"49",{"VOID":876},"1-11","2013-09-01",2013,{"id":880,"createTime":881,"updateTime":882,"relativeEntities":883,"slug":884,"properties":885,"entityType":688,"verifyStatus":25,"verifyTime":882,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":892,"fullTextUrl":26,"authors":893,"publicationType":747,"publisherRelationship":909,"citationCount":26,"citationInfo":26,"publishDate":923,"publishYear":924,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e3b7365d-5885-47a7-aa82-8792121ec984","2024-01-27T19:53:28.745+00:00","2025-02-09T05:10:41.900+00:00",[],"Anestesia-y-analgesia-fetales",{"references":886,"title":888,"doi":890},{"VOID":887},"Deprest, 2008, Fetal surgery for anesthesiologists, Curr. Opin. Anaesthesiol., 21, 298, 10.1097\u002FACO.0b013e3282ff8607\nDe Buck, 2008, Anesthesia for fetal surgery, Curr. Opin. Anaesthesiol., 21, 293, 10.1097\u002FACO.0b013e3282fe6e70\nFarmer, 1998, Fetal surgery: a brief review, Pediatr. Radiol., 28, 409, 10.1007\u002Fs002470050372\nMagner, 2005\nBronstein, 1986, Visceral nociception in developing rats, Dev. Psychobiol., 19, 473, 10.1002\u002Fdev.420190508\nFitzgerald, 1985, The post-natal development of cutaneous afferent fibre input and receptive field organization in the rat dorsal horn, J. Physiol., 364, 1, 10.1113\u002Fjphysiol.1985.sp015725\nFitzgerald, 1988, The development of activity evoked by fine diameter cutaneous fibres in the spinal cord of the newborn rat, Neurosci. Lett., 86, 161, 10.1016\u002F0304-3940(88)90564-2\nFitzgerald, 1991, A physiological study of the prenatal development of cutaneous sensory inputs to dorsal horn cells in the rat, J. Physiol., 432, 473, 10.1113\u002Fjphysiol.1991.sp018395\nSmith, 2000, Pain and stress in the human fetus, Eur. J. Obstet. Gynecol. Reprod. Biol., 92, 161, 10.1016\u002FS0301-2115(00)00441-3\nSemba, 1982, Ontogeny of the peptidergic system in the rat spinal cord: immunohistochemical analysis, J. Comp. Neurol., 208, 54, 10.1002\u002Fcne.902080105\nLeong, 1984, Localizing spinal cord projecting neurons in neonatal and immature albino rats, J. Comp. Neurol., 228, 18, 10.1002\u002Fcne.902280104\nFitzgerald, 1987, The postnatal development of the ventral root reflex in the rat; a comparative in vivo and in vitro study, Neurosci. Lett., 78, 41, 10.1016\u002F0304-3940(87)90558-1\nPickel, 1982, Early prenatal development of substance P and enkephalin-containing neurons in the rat, J. Comp. Neurol., 210, 411, 10.1002\u002Fcne.902100407\nAnand, 1987, Pain and its effects in the human neonate and fetus, N. Engl. J. Med., 317, 1321, 10.1056\u002FNEJM198711193172105\nLecanuet, 1989, Sensorialité fœtale. Ontogenèse des systèmes sensoriels, conséquences de leur fonctionnement fœtal, 201\nLee, 2005, Fetal pain: a systematic multidisciplinary review of the evidence, JAMA, 294, 947, 10.1001\u002Fjama.294.8.947\nLowery, 2007, Neurodevelopmental changes of fetal pain, Semin. Perinatol., 31, 275, 10.1053\u002Fj.semperi.2007.07.004\nGiannakoulopoulos, 1994, Fetal plasma cortisol and β-endorphin response to intrauterine needling, Lancet, 344, 77, 10.1016\u002FS0140-6736(94)91279-3\nSulmasy, 1999, The rule of double effect: clearing up the double talk, Arch. Intern. Med., 159, 545, 10.1001\u002Farchinte.159.6.545\nGerdin, 1990, Transplacental transfer of morphine in man, J. Perinat. Med., 18, 305, 10.1515\u002Fjpme.1990.18.4.305\nSpielman, 1984, Anesthesia for fetal surgery, Anesthesia, 39, 756, 10.1111\u002Fj.1365-2044.1984.tb06517.x\nSpencer, 1994, The effect of neuromuscular blockade on human fetal heart rate and its variation, Br. J. Obstet. Gynaecol., 101, 121, 10.1111\u002Fj.1471-0528.1994.tb13076.x\nDaffos, 1988, Fetal curarization for prenatal magnetic resonance imaging, Prenat. Diagn., 8, 312, 10.1002\u002Fpd.1970080412\nWilliamson, 1989, Magnetic resonance imaging of anomalous fetuses, Obstet. Gynecol., 73, 952\nRevel, 1993, Magnetic resonance imaging of the fetus: a study of 20 cases performed without curarization, Prenat. Diagn., 13, 775, 10.1002\u002Fpd.1970130902\nMyers, 2004, Fetal endoscopic surgery: indications and anaesthetic management, Best Pract. Res. Clin. Anaesthesiol., 18, 231, 10.1016\u002Fj.bpa.2004.01.001\nMyers, 2004, Epidural versus general anesthesia for twin-twin transfusion syndrome requiring fetal surgery, Fetal Diagn. Ther., 19, 286, 10.1159\u002F000076713\nFisk, 2001, Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling, Anesthesiology, 95, 828, 10.1097\u002F00000542-200110000-00008\nHaram, 1980, Diazepam as an induction agent for caesarean section: a clinical and pharmacological study of fetal exposure, Br. J. Obstet. Gynaecol., 87, 506, 10.1111\u002Fj.1471-0528.1980.tb04587.x\nJauniaux, 1996, In-vivo study of diazepam transfer across the first trimester human placenta, Hum. Reprod., 11, 889, 10.1093\u002Foxfordjournals.humrep.a019272\nMissant, 2004, Remifentanil for foetal immobilisation and maternal sedation during endoscopic treatment of twin-to-twin transfusion syndrome: a preliminary dose-finding study, Acta Anaesthesiol. Belg., 55, 239\nMoise, 1989, Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization, Obstet. Gynecol., 74, 905\nNatori M, Ishimoto H, Myazaki T. Intervention in the fetuses with pleural effusion. [Abstract]. 2nd World congress of Perinatal Medicine, Rome, 1993.\nNakano, 1991, Anesthesia for cesarean section in patients with fetal anomaly, Masui, 40, 738\nHanley, 1994, Fetal cardiac surgery, Adv. Card. Surg., 5, 47\nHarrison, 1990, Antenatal intervention for congenital cystic adenomatoid malformation, Lancet, 336, 965, 10.1016\u002F0140-6736(90)92420-M\nEsteve, 1992, Bilan de cinq années de chirurgie expérimentale in utero pour la réparation des hernies diaphragmatiques, Ann. Fr. Anesth. Reanim., 11, 193, 10.1016\u002FS0750-7658(05)80012-7\nRychik, 2004, Acute cardiovascular effects of fetal surgery in the human, Circulation, 110, 1549, 10.1161\u002F01.CIR.0000142294.95388.C4\nGoodman, 1997, Changing tactics in the abortion argument: does a fetus feel pain?, Br. J. Hosp. Med., 58, 550\nMcMahan, 2006, Paradoxes of abortion and prenatal injury, Ethics, 116, 625, 10.1086\u002F504621\nWenger, 2006, Fetal pain legislation. Subordinating sound medical findings to moral and political agendas, J. Leg. Med., 27, 459, 10.1080\u002F01947640601021089\n2005, Respecting women's rights and fetal value: reflections on the question of fetal anesthesia, Conscience, 26, 39\nPreston, 2004, NY US Court in New York rejects partial-birth abortion ban, Times, A12\nGupta, 2007, On the nature, assessment, and treatment of fetal pain: neurobiological bases, pragmatic issues, and ethical concerns, Pain Phys, 10, 525\nSenat, 2002, Funipuncture for fetocide in late termination of pregnancy, Prenat. Diagn., 22, 354, 10.1002\u002Fpd.290\nNielsen, 1991, Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study, Reg. Anesth., 16, 28\nSenat, 2003, The use of lidocaine for fetocide in late termination of pregnancy, BJOG, 110, 296, 10.1046\u002Fj.1471-0528.2003.02217.x",{"ES":889},"Anestesia y analgesia fetales",{"VOID":891},"10.1016\u002Fs1283-081x(09)70784-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707842",[894],{"id":895,"sortIndex":36,"researcher":26,"roles":896,"affiliations":897,"properties":906},"11214995-34e8-4643-9bd6-5f5854c6190d",[696],[898],{"id":26,"sortIndex":36,"affiliation":899,"properties":26},{"id":900,"createTime":901,"updateTime":901,"relativeEntities":902,"slug":26,"properties":903,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"14238574-459e-4dc0-8c5c-1e270f52bbe8","2024-01-27T19:53:28.757+00:00",[],{"title":904},{"VI":905},"Service de réanimation et médecine néonatale, Centre hospitalier de Poissy-Saint-Germain-en-Laye, 10, rue du Champ-Gaillard, 78303 Poissy, France",{"title":907},{"VI":908},"R. Lenclen",{"url":892,"publisher":910,"properties":918},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":911,"slug":662,"properties":912,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":915,"manageAffiliations":916,"indexDatabases":917,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":913,"title":914},{"VOID":665},{"EN":667},[],[],[],{"volume":919,"pages":921},{"VOID":920},"45",{"VOID":922},"1-6","2009-01-01",2009,{"id":926,"createTime":927,"updateTime":928,"relativeEntities":929,"slug":930,"properties":931,"entityType":688,"verifyStatus":25,"verifyTime":928,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":114,"primaryUrl":938,"fullTextUrl":26,"authors":939,"publicationType":747,"publisherRelationship":1015,"citationCount":26,"citationInfo":26,"publishDate":1028,"publishYear":1029,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"636ac85a-0cab-40f0-8e99-7c7638fee9d0","2023-12-05T22:47:03.219+00:00","2024-12-24T14:38:17.687+00:00",[],"F%C3%ADstulas-obst%C3%A9tricas",{"references":932,"title":934,"doi":936},{"VOID":933},"UNFPA. New York: Campaign to end fistula.[Updated 2004; cited 02 November 2008]. Available from : http:\u002F\u002Fwww.endfistula.org\u002F.\nRijken, 2007, Urogenital and recto-vaginal fistulas in southern Malawi: a report on 407 patients, Int J Gynaecol Obstet, 99, S85, 10.1016\u002Fj.ijgo.2007.06.015\nHilton, 1998, Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years’ experience in southeast Nigeria, Int Urogynecol J Pelvic Floor Dysfunct, 9, 189, 10.1007\u002FBF01901602\nShittu, 2007, A review of postoperative care for obstetric fistulas in Nigeria, Int J Gynaecol Obstet, 99, S79, 10.1016\u002Fj.ijgo.2007.06.014\nCameroun. Enquête démographique et de santé et à indicateurs multiples 2011. Reproductive Health indicators. https:\u002F\u002Fwww.dhsprogram.com\u002FPubs\u002Fpdf\u002FFR260.pdf.\nMaheu-Giroux, 2015, Prevalence of symptoms of vaginal fistula in 19 sub-Saharan Africa countries: a meta-analysis of national household survey data, Lancet Glob Health, 3, e271, 10.1016\u002FS2214-109X(14)70348-1\nTebeu, 2015, Comparative study of the outcome of surgical management of vesico-vaginal fistulas with and without interposition of the Martius graft: a Cameroonian experience, Prog Urol, 25, 1225, 10.1016\u002Fj.purol.2015.07.005\nFalandry, 1992, Traitement des fistules uro-genitales postpartum en Afrique, 261 cas observés en dix ans, Prog Urol, 2, 861\nWall, 2004, The obstetric vesicovaginal fistula: characteristics of 899 patients from Jos, Nigeria, Am J Obstet Gynecol, 190, 1011, 10.1016\u002Fj.ajog.2004.02.007\nHolme, 2007, Obstetric fistulae: a study of women managed at the Monze Mission Hospital, Zambia, BJOG, 114, 1010, 10.1111\u002Fj.1471-0528.2007.01353.x\nMeyer, 2007, Commonalities among women who experienced vesicovaginal fistulae as a result of obstetric trauma in Niger: results from a survey given at the National Hospital Fistula Center, Niamey, Niger. Am J Obstet Gynecol, 197, 90\nArrowsmith, 1994, Genitourinary reconstruction in obstetric fistulas, J Urol, 152, 403, 10.1016\u002FS0022-5347(17)32749-0\nPaxton, 2006, The United Nations Process Indicators for emergency obstetric care: reflections based on a decade of experience, Int J Gynaecol Obstet, 95, 192, 10.1016\u002Fj.ijgo.2006.08.009\nEnquête démographique et de santé du Congo. EDSC-II 2011–2012. Caractéristiques sociodémographiques des enquêtés. https:\u002F\u002Fdhsprogram.com\u002Fpubs\u002Fpdf\u002FPR19\u002FPR19.pdf.\nTogo. Enquête démographique et de santé 2013–2014. https:\u002F\u002Fdhsprogram.com\u002Fpubs\u002Fpdf\u002FFR301\u002FFR301.pdf.\nGabon. Enquête démographique et de santé 2012. Santé de la reproduction. https:\u002F\u002Fgabon.unfpa.org\u002Fsites\u002Fdefault\u002Ffiles\u002Fpub-pdf\u002FEDS%20II.pdf.\nTchad. Enquête démographique et de santé et à indicateurs multiples au Tchad (EDS-MICS) 2014–2015. Santé de la reproduction. https:\u002F\u002Fdhsprogram.com\u002Fpubs\u002Fpdf\u002Ffr317\u002Ffr317.pdf.\nMaine, 1999, The Safe Motherhood Initiative: why has it stalled?, Am J Public Health, 89, 480, 10.2105\u002FAJPH.89.4.480\nTebeu, 2012, Risk factors for obstetric fistula: a clinical review, Int Urogynecol J, 23, 387, 10.1007\u002Fs00192-011-1622-x\nMelah, 2007, Risk factors for obstetric fistulae in north-eastern Nigeria, J Obstet Gynaecol, 27, 819, 10.1080\u002F01443610701709825\nUNFPA, EngenderHealth. Obstetric Fistula Needs Assessment Report: Findings from Nine African Countries. http:\u002F\u002Fwwwunfpa.org\u002Ffistula\u002Fdocs\u002Ffistula-needs-assessment.pdf.\nNiger. Enquête démographique et de santé et à indicateurs multiples 2006. Nomaou A, Harouna S. Planification familiale. https:\u002F\u002Fwww.dhsprogram.com\u002Fpubs\u002Fpdf\u002FFR193\u002FFR193-NI06.pdf.\nNigeria. Demographic and Health Survey 2003. Family Planning. https:\u002F\u002Fwwwdhsprogram com\u002Fpubs\u002Fpdf\u002FFR148\u002FFR148 pdf.\nTsafack M, Kengne RS. Planification familiale. 2004. http:\u002F\u002Fwwwmeasuredhs.com\u002Fpubs\u002Fpdf\u002FFR163\u002F05chapitre05.pdf.\nTebeu, 2007, Maternal mortality in Maroua Provincial Hospital, Cameroon (2003–2005), West Indian Med J, 56, 502\nTebeu, 2004, Devenir de l’accouchement aux âges extrêmes de la vie reproductive, Rev Med Liege, 59, 455\nChang, 2003, Characteristics and risk factors for adverse birth outcome in pregnant black adolescents, J Pediatr, 143, 250, 10.1067\u002FS0022-3476(03)00363-9\nTebeu, 2009, Risk factors for obstetric fistula in the Far North Province of Cameroon, Int J Gynaecol Obstet, 107, 12, 10.1016\u002Fj.ijgo.2009.05.019\nTebeu PM. Risk Factors of Obstetric Fistula in the far North Province of Cameroun [thesis]. Prince Leopold Institut of Tropical Medecine, Antwerp, Belgium; 2008.\nBarrère, 2004, Santé de la mère et de l’enfant, DHS Cameroon, 8, 139\nNafiou, 2007, Obstetric vesico-vaginal fistulas at the National Hospital of Niamey, Niger. Int J Gynaecol Obstet, 99, S71, 10.1016\u002Fj.ijgo.2007.06.012\nRamsey, 2007, Fistula Fortnight: innovative partnership brings mass treatment and public awareness towards ending obstetric fistula, Int J Gynaecol Obstet, 99, S130, 10.1016\u002Fj.ijgo.2007.06.034\nIjaiya, 2004, Obstetric urogenital fistula: the Ilorin experience, Nigeria, West Afr J Med, 23, 7, 10.4314\u002Fwajm.v23i1.28071\nAhmad, 2005, Management of vesico-vaginal fistulas in women, Int J Gynaecol Obstet, 88, 71, 10.1016\u002Fj.ijgo.2004.08.021\nCameroun. Enquête démographique et de santé 2018. Santé de la reproduction. Accouchement. https:\u002F\u002Fdhsprogramm.com\u002Fpubs\u002Fpdf\u002FPR116\u002FPR116.pdf.\nTebeu, 2012, Risk factors for obstetric vesicovaginal fistula at University Teaching Hospital, Yaounde, Cameroon, Int J Gynaecol Obstet, 118, 256, 10.1016\u002Fj.ijgo.2012.04.011\nQi Li Ya, 2000, Traitement des fistules vesico-vaginales à l’hôpital de Kati, à propos de 34 cas, Med Afr Noire, 47, 167\nHarouna, 2001, La fistule vésico-vaginale de cause obstétricale : enquête auprès de 52 femmes admises au village des fistuleuses, Med Afr Noire, 48, 55\nGessessew, 2003, Genitourinary and rectovaginal fistulae in Adigrat Zonal Hospital, Tigray, north Ethiopia, Ethiop Med J, 41, 123\nMuleta, 2004, Socio-demographic profile and obstetric experience of fistula patients managed at the Addis Ababa Fistula Hospital, Ethiop Med J, 42, 9\nTebeu PM, Rochat CH. Troisième mini campagne Fistule Obstétricale à Maroua-Cameroun. Prise en charge des femmes vivantes avec la fistule vésico-vaginale ou recto-vaginale. 8–18 mars 2007. http:\u002F\u002Fwww.gfmer.ch\u002FActivites_internationales_Fr\u002FTebeu_rapport_fistule_obstetricale_2007.htm.\nBaker, 2017, Barriers to obstetric fistula treatment in low-income countries: a systematic review, Trop Med Int Health, 22, 938, 10.1111\u002Ftmi.12893\nTebeu, 2010, Perception and attitude of obstetric fistula patients about their condition: a report from the regional hospital, Maroua, Cameroon, Urogynaecologia, 24, 5\nCamey, 1998\nTebeu, 2017, Tebeu's pronostic classification of obstetric fistula according to anatomopathologic variables from the University Teaching Hospital, Yaounde, Cameroon, Int J Reprod Med Gynecol, 3, 29\nLe Duc, 2013, Prise en charge chirurgicale des fistules obstétricales en Afrique, E-Mem Acad Natl Chir, 12, 076\nde Bernis, 2007, Obstetric fistula: guiding principles for clinical management and programme development, a new WHO guideline, Int J Gynaecol Obstet, 99, S117, 10.1016\u002Fj.ijgo.2007.06.032\n2011\nTebeu, 2017\nPaluku, 2016, Obstetric vesico-vaginal fistulae seen in the Northern Democratic Republic of Congo: a descriptive study, Afr Health Sci, 15, 1104, 10.4314\u002Fahs.v15i4.8\nDelamou, 2015, Good Clinical Outcome from a 7-year holistic programme of fistula repair in Guinea, Trop Med Int Health, 20, 813, 10.1111\u002Ftmi.12489\nAhmed, 2015, Burden of obstetric fistula: from measurement to action, Lancet Glob Health, 3, e243, 10.1016\u002FS2214-109X(15)70105-1\nTebeu, 2016\nTebeu, 2017\nSalman, 2017, Urinary bladder injury during cesarean delivery: maternal outcome from a contemporary large case series, Eur J Obstet Gynecol Reprod Biol, 213, 26, 10.1016\u002Fj.ejogrb.2017.04.007\nTsivian, 2012, Uretero-vesico-cervical fistula following a caesarean section: a unique case report, Int Urogynecol J, 23, 1639, 10.1007\u002Fs00192-012-1748-5\nMachado Junior, 2018, Vesicouterine Fistula (Youssef Syndrome): case report and literature review, Rev Bras Ginecol Obstet, 40, 563, 10.1055\u002Fs-0038-1666998\nPrasad Rao M, Datta DB, Vyas N, Nandy PR, Trivedi S, Singh PB. Post caesarean vesicouterine fistulae - Youssef-syndrome: our experience and review of published work. Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, 2010.\nCamey, 1998, Les fistules obstétricales, Progrès en urologie\nMubikayi, 2015, Place de la fribose dans la chirurgie réparatrice de la fistule vésico-vaginale d’origine obstétricale, Ann Afr Med, 8, 2101\nGenadry, 2007, Complex obstetric fistulas, Int J Gynecol Obstet, 99, S51, 10.1016\u002Fj.ijgo.2007.06.026\nEvans, 2001, Interposition flaps in transabdominal vesicovaginal fistula repairs: are they really necessary?, Urology, 57, 670, 10.1016\u002FS0090-4295(01)00933-5\n2006\nHillary, 2016, The aetiology, treatment, and outcome of urogenital fistulae managed in well- and low-resourced countries: a systematic review, Eur Urol, 70, 478, 10.1016\u002Fj.eururo.2016.02.015\nHusain, 2005, Surgical management of complex obstetric fistula in eritrea, J Womens Health, 14, 10.1089\u002Fjwh.2005.14.839\nFédération internationale de gynécologie et d’obstétrique (FIGO) : Manuel de formation à la chirurgie réparatrice de la fistule; 2007.\nRochat CH, Gueye SM, Colas JM, Dumurgier C, Falandry L, Blanchot J, et al. Fistules vésicovaginales et fistules obstétricales. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales - Urologie, 41-175, 2011.\nGoh, 2008, Modified vaginal surgical technique for the management of the lateral vesico-vaginal fistulae, Int Urogynecol J, 19, 677, 10.1007\u002Fs00192-007-0505-7\nKirschner, 2016, Urinary diversion for patients with inoperable obstetric vesicovaginal fistula: the Jos, Nigeria experience, Int Urogynecol J, 27, 865, 10.1007\u002Fs00192-015-2871-x\nBeauval, 2015, Cystectomie et dérivations urinaires: techniques et accompagnement, Prog Urol, 25, 900, 10.1016\u002Fj.purol.2015.09.016\nWall, 2008, Ethical aspects of urinary diversion for women with irreparable obstetric fistulas in developing countries, Int Urogynecol J, 19, 1027, 10.1007\u002Fs00192-008-0559-1\nWilkinson, 2016, The ethical and technical aspects of urinary diversions in low-resource settings: a commentary, BJOG, 123, 1273, 10.1111\u002F1471-0528.13934\nGutman, 2007, Complications of treatment of obstetric fistula in the developing world: Gynatresia, urinary incontinence, and urinary diversion, Int J Gynecol Obstet, 99, S57, 10.1016\u002Fj.ijgo.2007.06.027\nZerbib, 2002, Les dérivations urinaires, techniques chirurgicales, Prog Urol, 12, 857\nNorman, 2008, A modified Mainz II pouch technique for management of refractory vesicovaginal fistulas: patient focused outcomes, Int J Gynaecol Obstet, 101, 35, 10.1016\u002Fj.ijgo.2007.10.010\nPandey, 2017, Re: quality of life among women in Bangladesh following ileal conduit urinary diversion operations for irreparable vesicovaginal fistula and bladder exstrophy; observational study, BJOG, 124, 1908, 10.1111\u002F1471-0528.14775\nFalandry, 2016\nFleury, 2004, Dérivations urinaires cutanées continentes cathetérisables : indications et suivi à moyen terme, Rev Med Suisse\nTariel E, Mongiat Artus P, Meria P, Cortesse A, Desgrandchamps F, Teillac P. Entérocystoplastie de substitution chez l’homme (Hautmann exclu): principes et applications techniques. EMC (Elsevier Masson SAS, Paris), Techniques Chirurgicales - Urologie, 41-212, 2006.\nBenchekroun, 1995, Urostomie continente. Poche iléale et valve de Benchekroun, Prog Urol, 5, 245\nHenriet MP. Entérocystoplasties de dérivation continente. EMC (Elsevier Masson SAS, Paris), Techniques Chirurgicales - Urologie, 41-214, 1991.\nSalomé, 1997, La poche d’Indiana : une technique de dérivation urinaire continente simple, Prog Urol, 7, 415\nBladou, 1996, La poche de Miami : une dérivation urinaire continente fiable après exentération pelvienne, Prog Urol, 6, 217\nMhiri, 2007, Appendicovésicostomie de Mitrofanoff chez l’enfant : indications et résultats, Prog Urol, 17, 245, 10.1016\u002FS1166-7087(07)92272-1\nChabchoub, 2008, Dérivation urinaire de Mitrofanoff. Mécanismes physiques et explication urodynamique de la continence, Prog Urol, 18, 120, 10.1016\u002Fj.purol.2007.12.006\nThuroff, 1985, The Mainz Pouch for bladder augmentation and continent diversion, World J Urol, 3, 179, 10.1007\u002FBF00326990\nFisch, 1993, The Mainz pouch II (sigma rectum pouch), J Urol, 149, 258, 10.1016\u002FS0022-5347(17)36050-0\nBenchekroun, 1987, Fistules vésico-vaginales à propos de 600 cas, J Urol, 3, 151\nWall, 2007, The Continence gap: a critical concept in obstetric fistula repair, Urogynecol J Pelvic Floor Dysfunct, 18, 843, 10.1007\u002Fs00192-007-0367-z\nNardos, 2009, Risk factors that predict failure after vaginal repair of obstetric vesico-vaginal fistula, Am J Obstet Gynecol, 200, 578, 10.1016\u002Fj.ajog.2008.12.008\nDelamou, 2016, Factors associated with the failure of obstetric fistula repair in Guinea: implications for practice, Reprod Health, 13, 135, 10.1186\u002Fs12978-016-0248-3\nBarone, 2012, Determinants of postoperative outcomes of female genital fistula repair surgery, Obstet Gynecol, 120, 524, 10.1097\u002FAOG.0b013e31826579e8\nKirschner, 2010, Obstetric fistula: the ECWA evangel VVF center surgical experience from Jos, Nigeria, Int Urogynecol J, 21, 1525, 10.1007\u002Fs00192-010-1231-0\nGoh, 2008, Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system, Int Urogynecol J, 19, 1659, 10.1007\u002Fs00192-008-0693-9\nBrowning, 2004, Prevention of residual urinary incontinence following successful repair of obstetric vesico-vaginal fistula using a fibro-muscular sling, BJOG, 111, 357, 10.1111\u002Fj.1471-0528.2004.00080.x\nMurray, 2002, Urinary and faecal incontinence following delayed primary repair of obstetric genital fistula, BJOG, 109, 828, 10.1111\u002Fj.1471-0528.2002.00124.x\nKopp, 2019, Continence, quality of life and depression following surgical repair of obstetric vesico-vaginal fistula: a cohort study, BJOG, 126, 926, 10.1111\u002F1471-0528.15546\nBrowning, 2006, Risk factors for developing residual urinary incontinence after obstetric fistula repair, BJOG, 113, 482, 10.1111\u002Fj.1471-0528.2006.00875.x\nPetros, 2010, Tethered vagina syndrome. Reconstructive pelvic floor surgery according to the integral theory, 179\nCarey, 2002, Stress urinary incontinence after delayed closure of genitourinary fistula: a technique for surgical management, Am J Obstet Gynecol, 186, 948, 10.1067\u002Fmob.2002.122247\nGoh, 2013, Urinary symptoms and urodynamics following obstetric genitourinary fistula repair, Int Urogynecol J, 24, 947, 10.1007\u002Fs00192-012-1948-z\nKopp, 2019, Use of a postoperative pad test to identify continence status in women after obstetric vesico-vaginal fistula repair: a prospective cohort study, BJOG, 126, 926, 10.1111\u002F1471-0528.15546\nHancock B, Browning A. Practical obstetric fistula surgery. London: The Royal Society of Medecine Press; p. 113-4.\nBorazjani, 2015, Validation of a culturally compliant voiding platform for urodynamics in African vesico-vaginal fistula patients, Int Urogynecol J, 26, 749, 10.1007\u002Fs00192-014-2575-7\nBrowning, 2008, Women with obstetric fistula in Ethiopia: a 6-month follow up after surgical treatment, BJOG, 115, 1564, 10.1111\u002Fj.1471-0528.2008.01900.x\nPatwardhan, 2008, Simultaneous bladder and vaginal reconstruction using ileum in complicated vesico-vaginal fistula, Indian J Urol, 24, 348, 10.4103\u002F0970-1591.39546\nCastille, 2014, Impact of a program of physiotherapy and health education on the outcome of obstetric fistula surgery, Int J Gynaecol Obstet, 124, 77, 10.1016\u002Fj.ijgo.2013.06.032\nWaaldijk, 1994\nGallagher, 1995, Tanagho bladder neck reconstruction in the treatment of adult incontinence, J Urol, 153, 1451, 10.1016\u002FS0022-5347(01)67430-5\nLengmang, 2018, Pubovesical sling for residual incontinence after successful vesicovaginal fistula closure: a new approach to an old procedure, Int Urogynecol J, 29, 1551, 10.1007\u002Fs00192-018-3582-x\nAscher-Walsh, 2010, Sling procedures after repair of obstetric vesico-vaginal fistula in Niamey, Niger. Int Urogynecol J, 21, 1385, 10.1007\u002Fs00192-010-1202-5\nShortlife, 1982, Newer approaches to the correction of urinary stress incontinence in female patients, Surg Clin North Am, 62, 1035, 10.1016\u002FS0039-6109(16)42883-5\nZimmern, 1991, Bladder neck suspension using the modified Pereyra-Raz procedure in the treatment of stress urinary incontinence in women, J Urol, 97, 309\nFalandry, 2000, Vaginal route treatment for residual urinary incontinence after closing an obstetrical fistula: a propos of 49 cases, J Gynecol Obstet Biol Reprod, 29, 393\nImamura, 2019, Surgical interventions for women with stress urinary incontinence: systematic review and network meta-analysis of randomised controlled trials, Br Med J, 365, l1842, 10.1136\u002Fbmj.l1842\nGlazener, 2017, Bladder neck needle suspension for urinary incontinence in women, Cochrane Database Syst Rev\nIngelman-Sundberg, 1961, Result of Ingleman-Sundberg method in the treatment of stress incontinence in women, Pol Przegl Chir, 33, 1425\nHilton, 1998, Periurethral injection of autologous fat for the treatment of post fistula repair stress incontinence: a preliminary report, Int Urogynecol J Pelvic Floor Dysfunct, 9, 118, 10.1007\u002FBF01982221\nHamlin, 1969, Reconstruction of urethra totally destroyed in labour, Br Med J, 2, 147, 10.1136\u002Fbmj.2.5650.147\nPetros, 2015, Post vesico-vaginal fistula repair incontinence: a new hypothesis and classification potential guide prévention and cure, Pelviperineology, 34, 48\nGoh, 2005, Use of urethral plugs for urinary incontinence following fistula repair, Aust N Z J Obstet Gynecol, 45, 237, 10.1111\u002Fj.1479-828X.2005.00395.x\nBrook, 2013, Obstetric fistula: the use of urethral plugs for the management of persistent urinary incontinence following successful repair, Int Urogynecol J, 24, 479, 10.1007\u002Fs00192-012-1887-8\nBrowning, 2018, Skin flap vaginal augmentation helps prevent and cure post obstetric fistula repair urine leakage: a critical anatomical analysis, BJOG, 125, 745, 10.1111\u002F1471-0528.14953\nGoeshen, 2010, Tethered vagina syndrome: cure of severe involuntary urinary loss by skin graft to the bladder neck area of vagina, Pelviperineology, 29, 100",{"ES":935},"Fístulas obstétricas",{"VOID":937},"10.1016\u002Fs1283-081x(21)45129-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X21451295",[940,955,970,985,1000],{"id":941,"sortIndex":114,"researcher":26,"roles":942,"affiliations":943,"properties":952},"e3963cc6-4611-4db8-970d-a1f5c1ad0262",[696],[944],{"id":26,"sortIndex":36,"affiliation":945,"properties":26},{"id":946,"createTime":947,"updateTime":947,"relativeEntities":948,"slug":26,"properties":949,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"377f221f-5888-49c7-ad53-d65919681a37","2023-12-05T22:47:03.252+00:00",[],{"title":950},{"VI":951},"19, rue Julien-Feuvrier, 39100 Dole, France",{"title":953},{"VI":954},"J.-M. Colas",{"id":956,"sortIndex":36,"researcher":26,"roles":957,"affiliations":958,"properties":967},"f08226da-21d5-4a1c-8aa7-85dd62da5b47",[696],[959],{"id":26,"sortIndex":36,"affiliation":960,"properties":26},{"id":961,"createTime":962,"updateTime":962,"relativeEntities":963,"slug":26,"properties":964,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"86dea911-0360-476a-8aa1-932f83d13dca","2023-12-05T22:47:03.232+00:00",[],{"title":965},{"VI":966},"Montemart, 19360 Malemort-sur-Corrèze, France",{"title":968},{"VI":969},"C. Rosenthal",{"id":971,"sortIndex":59,"researcher":26,"roles":972,"affiliations":973,"properties":982},"bc9ade99-8c8e-450b-ba46-28c178e1ac9f",[696],[974],{"id":26,"sortIndex":36,"affiliation":975,"properties":26},{"id":976,"createTime":977,"updateTime":977,"relativeEntities":978,"slug":26,"properties":979,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"911eb668-e380-45e3-991b-d855851478dd","2023-12-05T22:46:45.368+00:00",[],{"title":980},{"VI":981},"Service urologie, Hôpital régional Labé, République de Guinée",{"title":983},{"VI":984},"K. Diallo",{"id":986,"sortIndex":111,"researcher":26,"roles":987,"affiliations":988,"properties":997},"b80018a7-4529-4d94-9da4-bd93a53caa19",[696],[989],{"id":26,"sortIndex":36,"affiliation":990,"properties":26},{"id":991,"createTime":992,"updateTime":992,"relativeEntities":993,"slug":26,"properties":994,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d09ee2cc-694e-4faa-96f5-624e7fc75560","2023-12-05T22:46:45.382+00:00",[],{"title":995},{"VI":996},"12, rue Isaac-Le-Chapelier, 35000 Rennes, France",{"title":998},{"VI":999},"J. Blanchot",{"id":1001,"sortIndex":115,"researcher":26,"roles":1002,"affiliations":1003,"properties":1012},"833e086e-2960-4535-8331-60c4451118c7",[696],[1004],{"id":26,"sortIndex":36,"affiliation":1005,"properties":26},{"id":1006,"createTime":1007,"updateTime":1007,"relativeEntities":1008,"slug":26,"properties":1009,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"780c4610-8df9-4b5a-baf1-312bd7623d7a","2024-01-29T08:40:13.324+00:00",[],{"title":1010},{"VI":1011},"Faculté de médecine et des sciences biomédicales, université de Yaoundé I, Cameroun",{"title":1013},{"VI":1014},"P.-M. Tebeu",{"url":938,"publisher":1016,"properties":1024},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1017,"slug":662,"properties":1018,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1021,"manageAffiliations":1022,"indexDatabases":1023,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1019,"title":1020},{"VOID":665},{"EN":667},[],[],[],{"volume":1025,"pages":1027},{"VOID":1026},"57",{"VOID":761},"2021-06-01",2021,{"id":1031,"createTime":1032,"updateTime":1033,"relativeEntities":1034,"slug":1035,"properties":1036,"entityType":688,"verifyStatus":25,"verifyTime":1033,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1043,"fullTextUrl":26,"authors":1044,"publicationType":747,"publisherRelationship":1111,"citationCount":26,"citationInfo":26,"publishDate":1124,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"ae90fcaa-5b47-44a7-8ecb-e4c0580df982","2024-01-16T22:01:37.077+00:00","2024-12-24T17:45:08.683+00:00",[],"Presentaciones-en-extensi%C3%B3n",{"references":1037,"title":1039,"doi":1041},{"VOID":1038},"Audra P, Thoulon JM, Balsan M. Présentation de la face. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-049-L-20, 1997.\nBourgeois L. Observations diverses sur la stérilité, perte de fruict, fœcondité, accouchements et maladies des femmes et des enfants nouveaux-nés. 1609.\nMauriceau F. Traité des maladies des femmes grosses 1668. https:\u002F\u002Fgallica.bnf.fr\u002Fark:\u002F12148\u002Fbpt6k553 texteImage. 2783\nBaudelocque JL. Principes de l’art des accouchements. 1787.\nDe La Chapelle ML. Pratique des accouchements. 1821-1825.\nDumont, 1962, Les présentations de la face, Gynecol Obstet, 61, 684\nZayed, 2008, Face and brow presentation in northern Jordan, over a decade of experience, Arch Gynecol Obstet, 278, 427, 10.1007\u002Fs00404-008-0600-0\nTapisiz, 2014, Face presentation at term: a forgotten issue, J Obstet Gynaecol Res, 40, 1573, 10.1111\u002Fjog.12369\nCruishank, 1981, Face and brow presentation, a review, Clin Obstet Gynecol, 24, 333, 10.1097\u002F00003081-198106000-00003\nDucarme, 2006, Présentation de la face : étude rétrospective de 32 cas à terme, Gynecol Obstet Fertil, 34, 393, 10.1016\u002Fj.gyobfe.2005.07.042\nWestgren, 1984, Face presentation in modern obstetrics – A study with special reference to fetal long term morbidity, Z Geburtshilfe Perinatol, 188, 87\nBalsan M. La présentation de la face à propos de 24 observations. Besançon, 1994.\nQuiel, 1991, Gesichtslagengeburten, Zentralbl Gynakol, 113, 1380\nThoulon, 1971, La présentation de la face, Rev Fr Gynecol Obstet, 66, 231\nChaoui, 1982, La présentation de la face, J Gynecol Obstet Biol Reprod, 11, 731\nBenedetti, 1980, Face presentation at term, Obstet Gynecol, 55, 199\nDuff, 1981, Diagnosis and management of face presentation, Obstet Gynecol, 57, 105\nAudra, 1988, Les présentations céphaliques défléchies. À propos de 80 observations, Rev Fr Gynecol Obstet, 83, 355\nShaffer, 2006, Face presentation: predictors and delivery route, Am J Obstet Gynecol, 194, e10, 10.1016\u002Fj.ajog.2005.11.029\nBhal, 1998, A population study of face and brow presentation, J Obstet Gynaecol, 18, 231, 10.1080\u002F01443619867371\nDumont, 1968, Les présentations du front (étude de 29 observations et comparaisons de deux séries de cas recueillis entre 1949-1954 et 1955-1966), Rev Fr Gynecol Obstet, 63, 225\nEijskoot, 1977, An ultrasonic device for continuous measurement of cervical dilation during labor, Ultrasonics, 15, 183, 10.1016\u002F0041-624X(77)90052-X\nFloberg, 1987, Influence of the pelvic outlet capacity on fetal head presentation at delivery, Acta Obstet Gynecol Scand, 66, 127, 10.3109\u002F00016348709083033\nMostar, 1966, Deflexion attitudes Median vertex persistent, brow, and face presentations, Obstet Gynecol, 28, 49\nPosner, 1943, Face and persistant brow presentation, Surg Gynecol Obstet, 77, 618\nPosner, 1975, Modern trends in the management of face and brow presentation, Surg Gynecol Obstet, 104, 485\nReddoch, 1948, Face presentation, Am J Obstet Gynecol, 56, 86, 10.1016\u002F0002-9378(48)90192-6\nPrevedourakis, 1966, Face presentation. An analysis of 163 cases, Am J Obstet Gynecol, 94, 1092, 10.1016\u002F0002-9378(66)90770-8\nRudolph, 1947, Face presentation, Am J Obstet Gynecol, 54, 987, 10.1016\u002FS0002-9378(16)39712-5\nJacobson, 1962, Brow face presentations, Am J Obstet Gynecol, 84, 1881, 10.1016\u002F0002-9378(62)90478-7\nMorris, 1953, Face brow presentations, J Obstet Gynaecol Br Emp, 60, 44, 10.1111\u002Fj.1471-0528.1953.tb06410.x\nArsene, 2016, Prenatal factors related to face presentation: a case-control study, Arch Gynecol Obstet, 294, 279, 10.1007\u002Fs00404-015-3992-7\nHellman, 1950, Face and brow presentations, Am J Obstet Gynecol, 59, 831, 10.1016\u002F0002-9378(50)90113-X\nFloberg, 1987, Influence of pelvic outlet capacity on labor. A prospective pelvimetry study of 1,429 unselected primiparas, Acta Obstet Gynecol Scand, 66, 121, 10.3109\u002F00016348709083032\nDede, 1963, Face presentation, Am J Obstet Gynecol, 87, 515, 10.1016\u002F0002-9378(63)90563-5\nIngoldsson, 1969, Brow presentation, Acta Obstet Gynecol Scand, 48, 486, 10.3109\u002F00016346909156664\nMandoul, 1983, Diagnostic anténatal d’une tumeur du cou par échographie, JEMU, 4, 155\nRuf, 1962, Déflexion primitive de la tête, Bull Fed Gynecol Obstet, 14, 171\nBorell, 1960, The mecanism of labour in face and brow presentation a radiologic study, Acta Obstet Gynecol Scand, 39, 626, 10.3109\u002F00016346009155741\nLau, 2009, Intrapartum translabial ultrasound demonstrating brow presentation during the second stage of labor, Int J Gynaecol Obstet, 107, 62, 10.1016\u002Fj.ijgo.2009.05.024\nNeuman, 1994, Intrapartum bimanual tocolytic-assisted reversal of face presentation: Preliminary report, Obstet Gynecol, 84, 146\nWhitacre, 1965, Forceps management of breech and face presentations, Clin Obstet Gynecol, 8, 882, 10.1097\u002F00003081-196512000-00007\nOffringa, 2019, Spatulas for entrapment of the after-coming head during vaginal breech delivery, Arch Gynecol Obstet, 299, 1283, 10.1007\u002Fs00404-019-05115-x\nDe Bernardo, 2017, Face presentation in delivery room: what is strategy?, BMJ Case Rep, 2017\nÖzdemir, 2018, Lip and face edema due to face presentation, J Pediatr Res, 5, 52, 10.4274\u002Fjpr.63626\nAudra, 1988, Monitoring of pregnancy and delivery in women over 40, Soins Gynecol Obstet Pueric Pediatr, 18\nThoulon, 1971, Transformation spontanée d’une attitude défléchie (front primitif en sommet dans les derniers mois de la grossesse), Bull Fed Gynecol Obstet, 23, 620\nLuker, 2005, Vaginal delivery of two cases of brow presentation using multiple Kiwi Omnicups, J Obstet Gynaecol, 25, 601, 10.1080\u002F01443610500242309\nHakmi, 2008, Brow presentation does not mean caesarean section, J Obstet Gynaecol, 28, 255, 10.1080\u002F01443610801976050\nGernez, 1978, La présentation du bregma, cette méconnue, Rev Fr Gynecol Obstet, 73, 757\nThoulon JM, Welfen-Ekra C, Arnould P, Audra P. Étude anatomoclinique et radiologique du bassin obstétrical. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-007-A-10, 1997.",{"ES":1040},"Presentaciones en extensión",{"VOID":1042},"10.1016\u002Fs1283-081x(20)43356-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20433569",[1045,1060,1075,1087,1099],{"id":1046,"sortIndex":36,"researcher":26,"roles":1047,"affiliations":1048,"properties":1057},"52b241a3-05f1-4e9f-b327-9576935c6f7f",[696],[1049],{"id":26,"sortIndex":36,"affiliation":1050,"properties":26},{"id":1051,"createTime":1052,"updateTime":1052,"relativeEntities":1053,"slug":26,"properties":1054,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6272e170-9888-4f00-8df9-3ed420a10323","2024-01-16T22:01:37.100+00:00",[],{"title":1055},{"VI":1056},"Service de gynécologie-obstétrique, CHU de Grenoble-Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France",{"title":1058},{"VI":1059},"D. Riethmuller",{"id":1061,"sortIndex":114,"researcher":26,"roles":1062,"affiliations":1063,"properties":1072},"404b4d19-6964-41b3-95b0-d366e21d1f3a",[696],[1064],{"id":26,"sortIndex":36,"affiliation":1065,"properties":26},{"id":1066,"createTime":1067,"updateTime":1067,"relativeEntities":1068,"slug":26,"properties":1069,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b408642c-87d7-462f-8f83-9992d6839849","2024-01-16T22:01:37.142+00:00",[],{"title":1070},{"VI":1071},"Pôle Mère-Femme, CHU de Besançon, Besançon, France",{"title":1073},{"VI":1074},"R. Ramanah",{"id":1076,"sortIndex":111,"researcher":26,"roles":1077,"affiliations":1078,"properties":1084},"3ce2cfb4-2d19-4ffa-b07b-2956c4d99f99",[696],[1079],{"id":26,"sortIndex":36,"affiliation":1080,"properties":26},{"id":1051,"createTime":1052,"updateTime":1052,"relativeEntities":1081,"slug":26,"properties":1082,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1083},{"VI":1056},{"title":1085},{"VI":1086},"V. Equy",{"id":1088,"sortIndex":59,"researcher":26,"roles":1089,"affiliations":1090,"properties":1096},"ecd3b28a-08e8-4bc3-95ca-40ff9c4eacb7",[696],[1091],{"id":26,"sortIndex":36,"affiliation":1092,"properties":26},{"id":1066,"createTime":1067,"updateTime":1067,"relativeEntities":1093,"slug":26,"properties":1094,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1095},{"VI":1071},{"title":1097},{"VI":1098},"L. Courtois",{"id":1100,"sortIndex":115,"researcher":26,"roles":1101,"affiliations":1102,"properties":1108},"8cb19c6a-9336-4882-a326-5e4431f596c9",[696],[1103],{"id":26,"sortIndex":36,"affiliation":1104,"properties":26},{"id":1066,"createTime":1067,"updateTime":1067,"relativeEntities":1105,"slug":26,"properties":1106,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1107},{"VI":1071},{"title":1109},{"VI":1110},"N. Mottet",{"url":1043,"publisher":1112,"properties":1120},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1113,"slug":662,"properties":1114,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1117,"manageAffiliations":1118,"indexDatabases":1119,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1115,"title":1116},{"VOID":665},{"EN":667},[],[],[],{"volume":1121,"pages":1122},{"VOID":759},{"VOID":1123},"1-13","2020-03-01",{"id":1126,"createTime":1127,"updateTime":1128,"relativeEntities":1129,"slug":1130,"properties":1131,"entityType":688,"verifyStatus":25,"verifyTime":1128,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1138,"fullTextUrl":26,"authors":1139,"publicationType":747,"publisherRelationship":1215,"citationCount":26,"citationInfo":26,"publishDate":1229,"publishYear":1230,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"06058d57-08af-47b2-998c-be20b2be0e34","2023-12-13T13:35:41.698+00:00","2025-01-11T17:50:30.306+00:00",[],"Utilidad-de-la-histeroscopia-diagn%C3%B3stica-en-el-estudio-de-la-infertilidad",{"references":1132,"title":1134,"doi":1136},{"VOID":1133},"Merviel, 2000, Place de l'hystéroscopie dans le diagnostic et le traitement de l'infertilité, Presse Méd., 29, 1302\nPrevedourakis, 1994, Hysterosalpingography and hysteroscopy in female infertility, Hum. Reprod., 9, 2353, 10.1093\u002Foxfordjournals.humrep.a138451\nPreutthipan, 2003, A prospective study between hysterosalpingography and hysteroscopy in the detection of intrauterine pathology in patients with infertility, J. Obstet. Gynaecol. Res., 29, 33, 10.1046\u002Fj.1341-8076.2003.00068.x\nWang, 1996, Comparison of hysterosalpingography and hysteroscopy in infertility, J. Am. Assoc. Gynecol. Laparosc., 3, 581, 10.1016\u002FS1074-3804(05)80170-7\nGolan, 1996, Hysteroscopy is superior to hysterosalpingography in infertility investigation, Acta Obstet. Gynecol. Scand., 75, 654, 10.3109\u002F00016349609054692\nLoverro, 2001, Uterine cavity assessment in infertile women: comparison of transvaginal sonography and hysteroscopy, Eur. J. Obstet. Gynecol. Reprod. Biol., 100, 67, 10.1016\u002FS0301-2115(01)00434-1\nShalev, 2000, Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility, Fertil. Steril., 73, 412, 10.1016\u002FS0015-0282(99)00533-6\nNarayan, 1993, Transvaginal sonography of the uterine cavity with hysteroscopic correlation in the investigation of infertility, Ultrasound Obstet. Gynecol., 3, 129, 10.1046\u002Fj.1469-0705.1993.03020129.x\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil. Steril., 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nHamilton, 1998, Routine use of saline hysterosonography in 500 consecutive, unselected, infertile women, Hum. Reprod., 13, 2463, 10.1093\u002Fhumrep\u002F13.9.2463\nDe Kroon, 2003, Technology assessment of saline contrast hysterosonography, Am. J. Obstet. Gynecol., 188, 945, 10.1067\u002Fmob.2003.264\nBrown, 2000, Evaluation of outpatient hysteroscopy,sline infusion hysterosonography,and hysterosalpingography in infertile women: a prospective, randomized study, Fertil. Steril., 74, 1029, 10.1016\u002FS0015-0282(00)01541-7\nAyida, 1997, Uterine cavity assessment prior to in vitro fertilization: comparison of transvaginal scanning, saline contrast hysterosonography and hysteroscopy, Ultrasound Obstet. Gynecol., 10, 59, 10.1046\u002Fj.1469-0705.1997.10010059.x\nLeone, 2003, Use of strict sonohysterographic methods for preoperative assessment of submucous myomas, Fertil. Steril., 79, 998, 10.1016\u002FS0015-0282(02)04916-6\nGronlund, 1999, Transvaginal sonohysterography and hysteroscopy in the evaluation of female infertility, habitual abortion or metrorrhagia. A comparative study, Acta Obstet. Gynecol. Scand., 78, 415, 10.1080\u002Fj.1600-0412.1999.780513.x\nAlatas, 1997, Evaluation of intrauterine abnormalities in infertile patients by sonohysterography, Hum. Reprod., 12, 487, 10.1093\u002Fhumrep\u002F12.3.487\nSchrager, 2004, Diethylstilbestrol exposure, Am. Fam. Physician., 69, 2395\nLitta, 2004, Hysteroscopic metroplasty under laparoscopic guidance in infertile women with septate uteri: follow-up of reproductive outcome, J. Reprod. Med., 49, 274\nKdous, 2003, Fertility after hysteroscopic treatment of intra-uterine adhesions, Gynecol. Obstet. Fertil., 31, 422, 10.1016\u002FS1297-9589(03)00101-2\nSchiano, 1999, The value of hysteroscopy after repeated implantation failures with in vitro fertilization, Contracept. Fertil. Sex., 27, 129\nFeghali, 2003, Systematic hysteroscopy prior to in vitro fertilization, Gynecol. Obstet Fertil., 31, 127\nSeneira, 1988, Hysteroscopy in an IVF-ER program, Acta Obstet. Gynecol. Scand., 67, 654\nLa Sala, 1985, Hysteroscopy and female sterility: analysis of the results from 213 patients, Acta Eur. Fertil., 16, 47\nShamma, 1992, The role of office hysteroscopy in in vitro fertilization, Fertil. Steril., 58, 1237, 10.1016\u002FS0015-0282(16)55576-9",{"ES":1135},"Utilidad de la histeroscopia diagnóstica en el estudio de la infertilidad",{"VOID":1137},"10.1016\u002Fs1283-081x(05)43391-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05433913",[1140,1155,1167,1179,1191,1203],{"id":1141,"sortIndex":115,"researcher":26,"roles":1142,"affiliations":1143,"properties":1152},"d6dbd2e1-8558-4eac-a153-334c9e2c8fb1",[696],[1144],{"id":26,"sortIndex":36,"affiliation":1145,"properties":26},{"id":1146,"createTime":1147,"updateTime":1147,"relativeEntities":1148,"slug":26,"properties":1149,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c372a8a2-1ab7-4b14-87b8-11b2ea4d64de","2023-12-13T13:35:41.742+00:00",[],{"title":1150},{"VI":1151},"Service de gynécologie obstétrique, hôpital La Conception, 147, boulevard Baille, Marseille 13005, France",{"title":1153},{"VI":1154},"F. Franchi",{"id":1156,"sortIndex":59,"researcher":26,"roles":1157,"affiliations":1158,"properties":1164},"cd449751-51dc-415e-84fe-71c7b6ee58d3",[696],[1159],{"id":26,"sortIndex":36,"affiliation":1160,"properties":26},{"id":1146,"createTime":1147,"updateTime":1147,"relativeEntities":1161,"slug":26,"properties":1162,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1163},{"VI":1151},{"title":1165},{"VI":1166},"V. Roger",{"id":1168,"sortIndex":111,"researcher":26,"roles":1169,"affiliations":1170,"properties":1176},"9290bb5b-fba7-4447-98f7-a095174ee880",[696],[1171],{"id":26,"sortIndex":36,"affiliation":1172,"properties":26},{"id":1146,"createTime":1147,"updateTime":1147,"relativeEntities":1173,"slug":26,"properties":1174,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1175},{"VI":1151},{"title":1177},{"VI":1178},"L. Cravello",{"id":1180,"sortIndex":36,"researcher":26,"roles":1181,"affiliations":1182,"properties":1188},"11aa1753-fcad-4bb2-b44d-0993f05ef7ae",[696],[1183],{"id":26,"sortIndex":36,"affiliation":1184,"properties":26},{"id":1146,"createTime":1147,"updateTime":1147,"relativeEntities":1185,"slug":26,"properties":1186,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1187},{"VI":1151},{"title":1189},{"VI":1190},"A. Agostini",{"id":1192,"sortIndex":162,"researcher":26,"roles":1193,"affiliations":1194,"properties":1200},"d18fbdec-9958-4c3d-8502-5a77de4309ee",[696],[1195],{"id":26,"sortIndex":36,"affiliation":1196,"properties":26},{"id":1146,"createTime":1147,"updateTime":1147,"relativeEntities":1197,"slug":26,"properties":1198,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1199},{"VI":1151},{"title":1201},{"VI":1202},"B. Blanc",{"id":1204,"sortIndex":114,"researcher":26,"roles":1205,"affiliations":1206,"properties":1212},"8be28c33-f4a2-4308-bbdc-282c87c480c5",[696],[1207],{"id":26,"sortIndex":36,"affiliation":1208,"properties":26},{"id":1146,"createTime":1147,"updateTime":1147,"relativeEntities":1209,"slug":26,"properties":1210,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1211},{"VI":1151},{"title":1213},{"VI":1214},"F. Bretelle",{"url":1138,"publisher":1216,"properties":1224},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1217,"slug":662,"properties":1218,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1221,"manageAffiliations":1222,"indexDatabases":1223,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1219,"title":1220},{"VOID":665},{"EN":667},[],[],[],{"volume":1225,"pages":1227},{"VOID":1226},"41",{"VOID":1228},"1-4","2005-01-01",2005,{"id":1232,"createTime":1233,"updateTime":1234,"relativeEntities":1235,"slug":1236,"properties":1237,"entityType":688,"verifyStatus":25,"verifyTime":1234,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1244,"fullTextUrl":26,"authors":1245,"publicationType":747,"publisherRelationship":1273,"citationCount":26,"citationInfo":26,"publishDate":1287,"publishYear":1288,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"50ebf169-0831-451c-8f10-6e009a7bb777","2024-01-18T02:06:57.968+00:00","2024-12-25T07:10:31.921+00:00",[],"S%C3%ADndrome-de-dolor-vesical-cistitis-intersticial",{"references":1238,"title":1240,"doi":1242},{"VOID":1239},"Gillenwater, 1988, Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on interstitial cystitis. Bethesda, Maryland, August 28-29, 1987, J Urol, 140, 203, 10.1016\u002FS0022-5347(17)41529-1\nHanno, 1999, The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health interstitial cystitis data base study, J Urol, 161, 553, 10.1016\u002FS0022-5347(01)61948-7\nAbrams, 2002, The standardisation of terminology of lower urinary tract function: report from the standardization subcommittee of the International Continence Society, Neurourol Urodyn, 21, 167, 10.1002\u002Fnau.10052\nDenson, 2000, Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis, J Urol, 164, 1908, 10.1016\u002FS0022-5347(05)66915-7\nDundore, 1996, Mast cell counts are not useful in the diagnosis of nonulcerative interstitial cystitis, J Urol, 155, 885, 10.1016\u002FS0022-5347(01)66334-1\nBade, 2003, Future research needs for the definition\u002Fdiagnosis of interstitial cystitis, Int J Urol, 10, S31, 10.1046\u002Fj.1442-2042.10.s1.9.x\nFuruya, 2007, Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome, Urology, 70, 922, 10.1016\u002Fj.urology.2007.06.1153\nVan De Merwe, 2008, Diagnostic criteria, classification and nomenclature for painful bladder syndrome\u002Finterstitial cystitis: an Essic proposal, Eur Urol, 53, 60, 10.1016\u002Fj.eururo.2007.09.019\nMoldwin, 2007, Rational approaches to the treatment of patients with interstitial cystitis, Urology, 69, 73, 10.1016\u002Fj.urology.2006.08.1105\nClauw, 1997, The relationship between fibromyalgia and interstitial cystitis, J Psychiatry Res, 31, 125, 10.1016\u002FS0022-3956(96)00051-9\nAlagiri, 1997, Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes, Urology, 49, 52, 10.1016\u002FS0090-4295(99)80332-X\nWarren, 2009, Antecedent nonbladder syndromes in case-control study of interstitial cystitis\u002Fpainful bladder syndrome, Urology, 73, 52, 10.1016\u002Fj.urology.2008.06.031\nKoziol, 1993, The natural history of interstitial cystitis: a survey of 374 patients, J Urol, 149, 465, 10.1016\u002FS0022-5347(17)36120-7\nSadhukhan, 2002, Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism, J Urol, 168, 289, 10.1016\u002FS0022-5347(05)64909-9\nMulholland, 1990, Pentosan polysulfate sodium therapy for interstitial cystitis, Urology, 35, 552, 10.1016\u002F0090-4295(90)80116-5\nParsons, 1993, A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosan polysulfate, J Urol, 150, 845, 10.1016\u002FS0022-5347(17)35629-X\nNickel, 2008, Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement, Urology, 71, 57, 10.1016\u002Fj.urology.2007.09.013\nHanno, 1994, Amitriptyline in the treatment of interstitial cystitis, Urol Clin North Am, 21, 89, 10.1016\u002FS0094-0143(21)00596-6\nSasaki, 2001, Oral Gabapentin (Neurontin) treatment of refractory genitourinary tract pain, Tech Urol, 7, 47\nSeshadri, 1994, Cimetidine in the treatment of interstitial cystitis, Urology, 44, 614, 10.1016\u002FS0090-4295(94)80074-X\nLewi, 1998, Cimetidine in the treatment of interstitial cystitis: 30-month follow-up, Br J Urol, 81, 42a\nThilagarajah, 2001, Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled Trial, BJU Int, 87, 207, 10.1046\u002Fj.1464-410x.2001.02031.x\nSairanen, 2005, Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study, J Urol, 174, 2235, 10.1097\u002F01.ju.0000181808.45786.84\nParkin, 1997, Intravesical Dimethyl Sulfoxide (DMSO) for interstitial cystitis: a practical approach, Urology, 49, 105, 10.1016\u002FS0090-4295(97)00181-7\nGhoniem, 1993, Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy, World J Urol, 11, 178, 10.1007\u002FBF00211416\nParsons, 1994, Treatment of interstitial cystitis with intravesical heparin, Br J Urol, 73, 504, 10.1111\u002Fj.1464-410X.1994.tb07634.x\nPropert, 2008, Interstitial cystitis clinical trials group. followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus calmette-guerin or placebo, J Urol, 179, 552, 10.1016\u002Fj.juro.2007.09.035\nPayne, 2005, Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, doubleblind, placebo controlled trial, J Urol, 173, 1590, 10.1097\u002F01.ju.0000154631.92150.ef\nChenTY, 2005, Prospective, Randomized, Double-Blind Study Of SafetyAnd Tolerability Of Intravesical Resiniferatoxin (Rtx) In Interstitial Cystitis (Ic), Int Urogynecol J Pelvic Floor Dysfunct, 16, 293, 10.1007\u002Fs00192-005-1307-4\nSmith, 2004, Botulinum Toxin A has antinociceptive effects in treating interstitial cystitis, Urology, 64, 871, 10.1016\u002Fj.urology.2004.06.073\nKuo, 2005, Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis, Urol Int, 75, 170, 10.1159\u002F000087173\nHsin-Tzu, 2007, Intravesical Botulinum Toxin A Injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis, Urology, 70, 463, 10.1016\u002Fj.urology.2007.04.038\nWhitmore, 2003, Sacral Neuromodulation In Patients With Interstitial Cystitis: A Multicenter Clinical Trial, Int Urogynecol J Pelvic Floor Dysfunct, 14, 305, 10.1007\u002Fs00192-003-1080-1\nVan Ophoven, 2002, Long-term results of trigonepreserving orthotopic substitution enterocystoplasty for interstitial cystitis, J Urol, 167, 603, 10.1016\u002FS0022-5347(01)69094-3",{"ES":1241},"Síndrome de dolor vesical\u002Fcistitis intersticial",{"VOID":1243},"10.1016\u002Fs1283-081x(12)61924-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X12619249",[1246,1261],{"id":1247,"sortIndex":115,"researcher":26,"roles":1248,"affiliations":1249,"properties":1258},"690c7ff2-4a45-432e-bf96-dbfed8b717cd",[696],[1250],{"id":26,"sortIndex":36,"affiliation":1251,"properties":26},{"id":1252,"createTime":1253,"updateTime":1253,"relativeEntities":1254,"slug":26,"properties":1255,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8037e446-6235-4fc4-9808-2be815c43781","2024-01-18T02:06:57.991+00:00",[],{"title":1256},{"VI":1257},"Service d’urologie, Nouvel hôpital civil, Université de Strasbourg, 1, place de l’Hôpital, 67091 Strasbourg, France",{"title":1259},{"VI":1260},"C. Saussine",{"id":1262,"sortIndex":36,"researcher":26,"roles":1263,"affiliations":1264,"properties":1270},"c7874190-5a9a-4581-8275-1725571c424e",[696],[1265],{"id":26,"sortIndex":36,"affiliation":1266,"properties":26},{"id":1252,"createTime":1253,"updateTime":1253,"relativeEntities":1267,"slug":26,"properties":1268,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1269},{"VI":1257},{"title":1271},{"VI":1272},"P. Mouracadé",{"url":1244,"publisher":1274,"properties":1282},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1275,"slug":662,"properties":1276,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1279,"manageAffiliations":1280,"indexDatabases":1281,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1277,"title":1278},{"VOID":665},{"EN":667},[],[],[],{"volume":1283,"pages":1285},{"VOID":1284},"48",{"VOID":1286},"1-8","2012-04-01",2012,{"id":1290,"createTime":1291,"updateTime":1292,"relativeEntities":1293,"slug":1294,"properties":1295,"entityType":688,"verifyStatus":25,"verifyTime":1292,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1302,"fullTextUrl":26,"authors":1303,"publicationType":747,"publisherRelationship":1433,"citationCount":26,"citationInfo":26,"publishDate":1446,"publishYear":1029,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a7721f00-3f8a-47c7-8f1c-a4449b687442","2024-01-03T14:07:46.155+00:00","2024-12-25T06:10:31.985+00:00",[],"Tratamiento-del-c%C3%A1ncer-de-mama-infiltrante-localizado-nuevos-desaf%C3%ADos",{"references":1296,"title":1298,"doi":1300},{"VOID":1297},"Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018 - Volume 1 : Tumeurs solides : Étude à partir des registres des cancers du réseau Francim [Internet]. 2019. Disponible sur : https:\u002F\u002Fwww.santepubliquefrance.fr\u002Fmaladies-et-traumatismes\u002Fcancers\u002Fcancer-du-sein\u002Fdocuments\u002Frapport-synthese\u002Festimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-volume-1-tumeurs-solides-etud.\nEl-Tamer, 2009, Surgical options as quality of care indicators in breast cancer, J Surg Oncol, 99, 393, 10.1002\u002Fjso.21148\nSakorafas, 2001, Breast cancer surgery--historical evolution, current status and future perspectives, Acta Oncol, 40, 5, 10.1080\u002F028418601750070984\nBuchholz, 2014, Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology Endorsement of the Society of Surgical Oncology\u002FAmerican Society for Radiation Oncology Consensus Guideline, J Clin Oncol, 32, 1502, 10.1200\u002FJCO.2014.55.1572\nVincent, 2017, Synthèse des recommandations nationales et internationales concernant les indications de la technique du ganglion sentinelle et du curage axillaire complémentaire après ganglion sentinelle positif dans la prise en charge des cancers du sein, Bull Cancer, 104, 356, 10.1016\u002Fj.bulcan.2017.01.001\nAFSOS. Prise en charge du lymphœdème secondaire du membre supérieur après cancer du sein. Mars 2014.\nGiuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial, JAMA, 318, 918, 10.1001\u002Fjama.2017.11470\nGalimberti, 2013, Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncol, 14, 297, 10.1016\u002FS1470-2045(13)70035-4\nSolá, 2013, Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\u002F13\u002F2000, Ann Surg Oncol, 20, 120, 10.1245\u002Fs10434-012-2569-y\nDonker, 2014, Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial, Lancet Oncol, 15, 1303, 10.1016\u002FS1470-2045(14)70460-7\nSávolt, 2017, Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial, Eur J Surg Oncol, 43, 672, 10.1016\u002Fj.ejso.2016.12.011\nGradishar, 2017, NCCN guidelines insights: breast cancer, version 1.2017, J Natl Compr Canc Netw, 15, 433, 10.6004\u002Fjnccn.2017.0044\nLyman, 2017, Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, J Clin Oncol, 35, 561, 10.1200\u002FJCO.2016.71.0947\nGnant, 2017, St. Gallen\u002FVienna 2017: a brief summary of the consensus discussion about escalation and de-escalation of primary breast cancer treatment, Breast Care, 12, 102, 10.1159\u002F000475698\nCostaz, 2019, Stratégies en cas de positivité du ganglion sentinelle dans les cancers du sein, Bull Cancer\nFisher, 1997, Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18, J Clin Oncol, 15, 2483, 10.1200\u002FJCO.1997.15.7.2483\nVila, 2014, Conservative surgery for ipsilateral breast tumor recurrence, J Surg Oncol, 110, 62, 10.1002\u002Fjso.23629\nGentilini, 2012, Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates, Ann Surg Oncol, 19, 3771, 10.1245\u002Fs10434-012-2404-5\nHannoun-Levi, 2013, Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group, Radiother Oncol, 108, 226, 10.1016\u002Fj.radonc.2013.03.026\nOr Z. Variations des pratiques chirurgicales dans la prise en charge des cancers du sein en France. 2017.\nBailey, 2017, Quality-of-life outcomes improve with nipple-sparing mastectomy and breast reconstruction, Plast Reconstr Surg, 140, 219, 10.1097\u002FPRS.0000000000003505\nMota, 2016, Nipple- and areola-sparing mastectomy for the treatment of breast cancer, Cochrane Database Syst Rev, CD008932\nWeber, 2018, Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy, Breast Cancer Res Treat, 172, 523, 10.1007\u002Fs10549-018-4937-1\nEssai clinique cancer Sein\u002FSein clos aux inclusions [Internet]. [cité 19 nov 2019]. Disponible sur : https:\u002F\u002Fwww.e-cancer.fr\u002FProfessionnels-de-sante\u002FLe-registre-des-essais-cliniques\u002FLe-registre-des-essais-cliniques\u002FEtudes-cliniques\u002FEtude-MAPAM-01-Etude-de-chirurgie-evaluant-l-efficacite-d-une-mastectomie-avec-conservation-de-l-etui-cutane-et-de-la-plaque-areolomamelonnaire-MCPAM-chez-des-patientes-ayant-un-carcinome-mammaire.-essai-clos-aux-inclusions.\nEarly Breast Cancer Trialists’ Collaborative Group (EBCTCG), 2011, Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, Lancet, 378, 1707, 10.1016\u002FS0140-6736(11)61629-2\nHennequin, 2016, Radiothérapie du cancer du sein, Cancer Radiother, 20, S139, 10.1016\u002Fj.canrad.2016.07.025\nStrnad, 2016, Lancet, 387, 229, 10.1016\u002FS0140-6736(15)00471-7\nVeronesi, 2013, Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial, Lancet Oncol, 14, 1269, 10.1016\u002FS1470-2045(13)70497-2\nVaidya, 2014, Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial, Lancet, 383, 603, 10.1016\u002FS0140-6736(13)61950-9\nVicini, 2019, Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial, Lancet, 394, 2155, 10.1016\u002FS0140-6736(19)32514-0\nWhelan, 2019, External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial, Lancet, 394, 2165, 10.1016\u002FS0140-6736(19)32515-2\nRivera, 2019, Hypofractionated radiation therapy for invasive breast cancer: from moderate to extreme protocols, Cancer Radiother, 23, 874, 10.1016\u002Fj.canrad.2019.09.002\nOffersen, 2016, ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1, Radiother Oncol, 118, 205, 10.1016\u002Fj.radonc.2015.12.027\nBartelink, 2007, Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial, J Clin Oncol, 25, 3259, 10.1200\u002FJCO.2007.11.4991\nSTART Trialists’ Group, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet Oncol, 9, 331, 10.1016\u002FS1470-2045(08)70077-9\nSTART Trialists’ Group, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet, 371, 1098, 10.1016\u002FS0140-6736(08)60348-7\nGiraud, 2012, Contribution of respiratory gating techniques for optimization of breast cancer radiotherapy, Cancer Invest, 30, 323, 10.3109\u002F07357907.2012.657818\nBalic, 2019, St. Gallen\u002FVienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment, Breast Care, 14, 103, 10.1159\u002F000499931\nJagsi, 2018, Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction, J Natl Cancer Inst, 110, 10.1093\u002Fjnci\u002Fdjx148\nKrug, 2019, Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials, Ann Surg Oncol, 26, 3892, 10.1245\u002Fs10434-019-07635-x\nNational Surgical Adjuvant Breast and Bowel Project (NSABP) [Internet]. [cité 21 févr 2020]. Disponible sur : http:\u002F\u002Fwww.nsabp.pitt.edu\u002FB-51.asp.\nFourquet, 1994, Les résultats à long terme des traitements conservateurs du cancer du sein. Résultats à long terme, Trait Conserv Cancer Sein, 4, 40\nFitzgibbons, 2000, Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med, 124, 966, 10.5858\u002F2000-124-0966-PFIBC\nAdami, 1986, The relation between survival and age at diagnosis in breast cancer, N Engl J Med, 315, 559, 10.1056\u002FNEJM198608283150906\nAnonyme. Facteurs pronostiques de l’évolution de la maladie loco-régionale ou métastatique et facteurs prédictifs de la réponse au traitement. Cancers du sein non métastatiques. Standards, Options et Recommandations. 1996. (FNCLCC).\nCarter, 1989, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, 63, 181, 10.1002\u002F1097-0142(19890101)63:1\u003C181::AID-CNCR2820630129>3.0.CO;2-H\nde Mascarel, 1992, Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up, Br J Cancer, 66, 523, 10.1038\u002Fbjc.1992.306\nvan der Heiden-van der Loo, 2013, Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes, Ann Oncol, 24, 2794, 10.1093\u002Fannonc\u002Fmdt243\nEllis, 1992, Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up, Histopathology, 20, 479, 10.1111\u002Fj.1365-2559.1992.tb01032.x\nElston, 1991, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, 19, 403, 10.1111\u002Fj.1365-2559.1991.tb00229.x\nAndre, 2005, Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer, J Clin Oncol, 23, 2996, 10.1200\u002FJCO.2005.08.046\nBollet, 2006, Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study, Eur J Cancer, 42, 2286, 10.1016\u002Fj.ejca.2006.03.026\nChakravarthy, 2006, Neoadjuvant concurrent paclitaxel and radiation in stage II\u002FIII breast cancer, Clin Cancer Res, 12, 1570, 10.1158\u002F1078-0432.CCR-05-2304\nde Mascarel, 1998, Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers, Eur J Cancer, 34, 58, 10.1016\u002FS0959-8049(97)00344-4\n1999, [Recommendations for the immunohistochemistry of the hormonal receptors on paraffin sections in breast cancer. Update 1999. Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC)], Ann Pathol, 19, 336\nFisher, 1988, Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06, J Clin Oncol, 6, 1076, 10.1200\u002FJCO.1988.6.7.1076\nMcGuire, 1992, Prognostic factors and treatment decisions in axillary-node-negative breast cancer, N Engl J Med, 326, 1756, 10.1056\u002FNEJM199206253262607\nClark, 1994, Prognostic factors: rationale and methods of analysis and integration, Breast Cancer Res Treat, 32, 105, 10.1007\u002FBF00666211\n1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists’ Collaborative Group, Lancet, 339, 71\nPenault-Llorca, 2014, 2014 update of the GEFPICS’ recommendations for HER2 status determination in breast cancers in France, Ann Pathol, 34, 352, 10.1016\u002Fj.annpat.2014.08.018\nWolff, 2018, Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\u002FCollege of American Pathologists Clinical Practice Guideline Focused Update, Arch Pathol Lab Med, 142, 1364, 10.5858\u002Farpa.2018-0902-SA\nLuporsi, 2012, Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review, Breast Cancer Res Treat, 132, 895, 10.1007\u002Fs10549-011-1837-z\nde Azambuja, 2007, Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients, Br J Cancer, 96, 1504, 10.1038\u002Fsj.bjc.6603756\nViale, 2008, Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole, J Clin Oncol, 26, 5569, 10.1200\u002FJCO.2008.17.0829\nCheang, 2009, Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer, J Natl Cancer Inst, 101, 736, 10.1093\u002Fjnci\u002Fdjp082\nViale, 2008, Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer, J Natl Cancer Inst, 100, 207, 10.1093\u002Fjnci\u002Fdjm289\nPenault-Llorca, 2009, Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer, J Clin Oncol, 27, 2809, 10.1200\u002FJCO.2008.18.2808\nSalgado, 2015, The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014, Ann Oncol, 26, 259, 10.1093\u002Fannonc\u002Fmdu450\nLoi, 2019, Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers, J Clin Oncol, 37, 559, 10.1200\u002FJCO.18.01010\nLook, 2002, Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients, J Natl Cancer Inst, 94, 116, 10.1093\u002Fjnci\u002F94.2.116\nPerou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038\u002F35021093\nCardoso, 2016, 70-Gene signature as an aid to treatment decisions in early-stage breast cancer, N Engl J Med, 375, 717, 10.1056\u002FNEJMoa1602253\nSparano, 2018, Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer, N Engl J Med, 379, 111, 10.1056\u002FNEJMoa1804710\nYann C. Haute Autorité de santé. 2019.\nLehmann, 2011, Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Invest, 121, 2750, 10.1172\u002FJCI45014\nPlanes-Laine, 2019, PD-1\u002FPD-L1 targeting in breast cancer: the first clinical evidences are emerging: a literature review, Cancers, 11, 10.3390\u002Fcancers11071033\nValagussa, 1978, Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients, Cancer, 41, 1170, 10.1002\u002F1097-0142(197803)41:3\u003C1170::AID-CNCR2820410355>3.0.CO;2-I\nChia, 2008, Locally advanced and inflammatory breast cancer, J Clin Oncol, 26, 786, 10.1200\u002FJCO.2008.15.0243\n2018, Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials, Lancet Oncol, 19, 27, 10.1016\u002FS1470-2045(17)30777-5\nvon Minckwitz, 2012, Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes, J Clin Oncol, 30, 1796, 10.1200\u002FJCO.2011.38.8595\nBonnefoi, 2014, Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994\u002FBIG 1-00 phase III trial, Ann Oncol, 25, 1128, 10.1093\u002Fannonc\u002Fmdu118\nCortazar, 2014, Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis, Lancet, 384, 164, 10.1016\u002FS0140-6736(13)62422-8\nCardoso, 2019, Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†, Ann Oncol, 30, 1194, 10.1093\u002Fannonc\u002Fmdz173\n1998, Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group, Lancet, 352, 930, 10.1016\u002FS0140-6736(98)03301-7\n2005, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, 365, 1687, 10.1016\u002FS0140-6736(05)66544-0\nMartin, 2003, Ann Oncol, 14, 833, 10.1093\u002Fannonc\u002Fmdg260\nFumoleau, 2003, Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial, J Clin Oncol, 21, 298, 10.1200\u002FJCO.2003.04.148\nBria, 2006, Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients, Cancer, 106, 2337, 10.1002\u002Fcncr.21886\nFerguson, 2007, Taxanes for adjuvant treatment of early breast cancer, Cochrane Database Syst Rev, CD004421\nJacquin, 2012, Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials, Breast Cancer Res Treat, 134, 903, 10.1007\u002Fs10549-011-1933-0\nDe Laurentiis, 2008, Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials, J Clin Oncol, 26, 44, 10.1200\u002FJCO.2007.11.3787\nQin, 2011, Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients, PLoS One, 6, e26946, 10.1371\u002Fjournal.pone.0026946\nEarly Breast Cancer Trialists’ Collaborative Group (EBCTCG), 2012, Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials, Lancet, 379, 432, 10.1016\u002FS0140-6736(11)61625-5\nShao, 2012, Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials, Breast, 21, 389, 10.1016\u002Fj.breast.2012.03.011\nSparano, 2008, Weekly paclitaxel in the adjuvant treatment of breast cancer, N Engl J Med, 358, 1663, 10.1056\u002FNEJMoa0707056\nNitz, 2017, Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression, Ann Oncol, 28, 2899, 10.1093\u002Fannonc\u002Fmdw349\n2019, Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials, Lancet, 393, 1440, 10.1016\u002FS0140-6736(18)33137-4\nLohrisch, 2006, Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer, J Clin Oncol, 24, 4888, 10.1200\u002FJCO.2005.01.6089\nBurstein, 2019, Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019, Ann Oncol, 30, 1541, 10.1093\u002Fannonc\u002Fmdz235\nSparano, 2015, Prospective validation of a 21-gene expression assay in breast cancer, N Engl J Med, 373, 2005, 10.1056\u002FNEJMoa1510764\nSparano, 2019, Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the TAILORx randomized clinical trial, JAMA Oncol, 6, 367, 10.1001\u002Fjamaoncol.2019.4794\nSparano, 2019, Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer, N Engl J Med, 380, 2395, 10.1056\u002FNEJMoa1904819\nCurigliano, 2017, De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017, Ann Oncol, 28, 1700, 10.1093\u002Fannonc\u002Fmdx308\nFrancis, 2018, Tailoring adjuvant endocrine therapy for premenopausal breast cancer, N Engl J Med, 379, 122, 10.1056\u002FNEJMoa1803164\nGnant, 2015, Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12, Ann Oncol, 26, 313, 10.1093\u002Fannonc\u002Fmdu544\nBlum, 2017, Anthracyclines in early breast cancer: The ABC Trials-USOR 06-090, NSABP B-46-I\u002FUSOR 07132, and NSABP B-49 (NRG Oncology), J Clin Oncol, 35, 2647, 10.1200\u002FJCO.2016.71.4147\nNitz, 2019, West German Study PlanB Trial: adjuvant four cycles of epirubicin and cyclophosphamide plus docetaxel versus six cycles of docetaxel and cyclophosphamide in HER2-negative early breast cancer, J Clin Oncol, 37, 799, 10.1200\u002FJCO.18.00028\nEjlertsen, 2017, Adjuvant cyclophosphamide and docetaxel with or without epirubicin for early TOP2A-normal breast cancer: DBCG 07-READ, an open-label, Phase III, randomized trial, J Clin Oncol, 35, 2639, 10.1200\u002FJCO.2017.72.3494\nSpring, 2016, Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis, JAMA Oncol, 2, 1477, 10.1001\u002Fjamaoncol.2016.1897\nSemiglazov, 2007, Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer, Cancer, 110, 244, 10.1002\u002Fcncr.22789\nAlba, 2012, Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM\u002F2006-03, a multicenter, randomized, phase-II study, Ann Oncol, 23, 3069, 10.1093\u002Fannonc\u002Fmds132\nPalmieri, 2014, NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer, Breast Cancer Res Treat, 148, 581, 10.1007\u002Fs10549-014-3183-4\nEiermann, 2001, Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study, Ann Oncol, 12, 1527, 10.1023\u002FA:1013128213451\nCataliotti, 2006, Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative « Arimidex » Compared to Tamoxifen (PROACT) trial, Cancer, 106, 2095, 10.1002\u002Fcncr.21872\nSmith, 2005, Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial, J Clin Oncol, 23, 5108, 10.1200\u002FJCO.2005.04.005\nLeal, 2015, Neoadjuvant endocrine therapy for resectable breast cancer: a systematic review and meta-analysis, Breast, 24, 406, 10.1016\u002Fj.breast.2015.03.004\nMasuda, 2017, Adjuvant capecitabine for breast cancer after preoperative chemotherapy, N Engl J Med, 376, 2147, 10.1056\u002FNEJMoa1612645\nEllis, 2008, Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics, J Natl Cancer Inst, 100, 1380, 10.1093\u002Fjnci\u002Fdjn309\nPoggio, 2018, Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis, Ann Oncol, 29, 1497, 10.1093\u002Fannonc\u002Fmdy127\nLitton, 2018, Neoadjuvant talazoparib (TALA) for operable breast cancer patients with a BRCA mutation (BRCA+), J Clin Oncol, 36\nSchmid, 2017, Pembrolizumab (pembro) + chemotherapy (chemo) as neoadjuvant treatment for triple negative breast cancer (TNBC): preliminary results from KEYNOTE-173, J Clin Oncol, 35\nCameron, 2017, 11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial, Lancet, 389, 1195, 10.1016\u002FS0140-6736(16)32616-2\nPerez, 2014, Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831, J Clin Oncol, 32, 3744, 10.1200\u002FJCO.2014.55.5730\nSlamon, 2011, Adjuvant trastuzumab in HER2-positive breast cancer, N Engl J Med, 365, 1273, 10.1056\u002FNEJMoa0910383\nvon Minckwitz, 2017, Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer, N Engl J Med, 377, 122, 10.1056\u002FNEJMoa1703643\nTolaney, 2019, Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer, J Clin Oncol, 37, 1868, 10.1200\u002FJCO.19.00066\nGoldhirsch, 2013, 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial, Lancet, 382, 1021, 10.1016\u002FS0140-6736(13)61094-6\nPivot, 2013, 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial, Lancet Oncol, 14, 741, 10.1016\u002FS1470-2045(13)70225-0\nJoensuu, 2018, Effect of adjuvant trastuzumab for a duration of 9 weeks vs 1 year with concomitant chemotherapy for early human epidermal growth factor receptor 2-positive breast cancer: The SOLD Randomized Clinical Trial, JAMA Oncol, 4, 1199, 10.1001\u002Fjamaoncol.2018.1380\nConte, 2017, 9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: results of the phase III multicentric Italian study Short-HER, J Clin Oncol, 35\nEarl, 2019, 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial, Lancet, 393, 2599, 10.1016\u002FS0140-6736(19)30650-6\nMartin, 2017, Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Oncol, 18, 1688, 10.1016\u002FS1470-2045(17)30717-9\nBuzdar, 2007, Clin Cancer Res, 13, 228, 10.1158\u002F1078-0432.CCR-06-1345\nPierga, 2010, A multicenter randomized phase II study of sequential epirubicin\u002Fcyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients, Breast Cancer Res Treat, 122, 429, 10.1007\u002Fs10549-010-0939-3\nGianni, 2010, Lancet, 375, 377, 10.1016\u002FS0140-6736(09)61964-4\nvan Ramshorst, 2018, Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial, Lancet Oncol, 19, 1630, 10.1016\u002FS1470-2045(18)30570-9\nSchneeweiss, 2013, Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA), Ann Oncol, 24, 2278, 10.1093\u002Fannonc\u002Fmdt182\nvon Minckwitz, 2019, Trastuzumab emtansine for residual invasive HER2-positive breast cancer, N Engl J Med, 380, 617, 10.1056\u002FNEJMoa1814017\nUntch, 2012, Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial, Lancet Oncol, 13, 135, 10.1016\u002FS1470-2045(11)70397-7\nGuarneri, 2012, Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study, J Clin Oncol, 30, 1989, 10.1200\u002FJCO.2011.39.0823\nBaselga, 2012, Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial, Lancet, 379, 633, 10.1016\u002FS0140-6736(11)61847-3\nRobidoux, 2013, Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial, Lancet Oncol, 14, 1183, 10.1016\u002FS1470-2045(13)70411-X\nBonnefoi, 2015, Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study, Ann Oncol, 26, 325, 10.1093\u002Fannonc\u002Fmdu551\nCarey, 2016, Molecular heterogeneity and response to neoadjuvant human epidermal growth factor receptor 2 targeting in CALGB 40601, a randomized phase III trial of paclitaxel plus trastuzumab with or without lapatinib, J Clin Oncol, 34, 542, 10.1200\u002FJCO.2015.62.1268\nGianni, 2016, 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial, Lancet Oncol, 17, 791, 10.1016\u002FS1470-2045(16)00163-7\nHurvitz, 2018, Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial, Lancet Oncol, 19, 115, 10.1016\u002FS1470-2045(17)30716-7\n2015, Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials, Lancet, 386, 1353, 10.1016\u002FS0140-6736(15)60908-4\nBurstein, 2018, Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO Clinical Practice Guideline Focused Update, J Clin Oncol, 37, 423, 10.1200\u002FJCO.18.01160\nCuzick, 2010, Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial, Lancet Oncol, 11, 1135, 10.1016\u002FS1470-2045(10)70257-6\nRegan, 2011, Evaluating letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomized clinical trial at 8.1 years median follow-up, Lancet Oncol, 12, 1101, 10.1016\u002FS1470-2045(11)70270-4\nVelde, 2011, Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial, Lancet, 377, 321, 10.1016\u002FS0140-6736(10)62312-4\n2015, Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials, Lancet, 386, 1341, 10.1016\u002FS0140-6736(15)61074-1\nViale, 2011, Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial, Ann Oncol, 22, 2201, 10.1093\u002Fannonc\u002Fmdq738\nCoombes, 2007, Survival and safety of exemestane versus tamoxifen after 2-3 years’ tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial, Lancet, 369, 559, 10.1016\u002FS0140-6736(07)60200-1\nBoccardo, 2005, Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial, J Clin Oncol, 23, 5138, 10.1200\u002FJCO.2005.04.120\nJakesz, 2005, Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial, Lancet, 366, 455, 10.1016\u002FS0140-6736(05)67059-6\nSestak, 2015, Markers for the identification of late breast cancer recurrence, Breast Cancer Res, 17, 10, 10.1186\u002Fs13058-015-0516-0\nJakesz, 2007, Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a, J Natl Cancer Inst, 99, 1845, 10.1093\u002Fjnci\u002Fdjm246\nMamounas, 2008, Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the national surgical adjuvant breast and bowel project B-33 Trial, J Clin Oncol, 26, 1965, 10.1200\u002FJCO.2007.14.0228\nJin, 2011, Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 Trial: analyses adjusting for treatment crossover, J Clin Oncol, 30, 718, 10.1200\u002FJCO.2010.34.4010\nMore on the ABCSG-16 Trial - The ASCO Post [Internet]. [cité 3 févr 2020]. Disponible sur : https:\u002F\u002Fwww.ascopost.com\u002Fissues\u002Fapril-10-2018\u002Fmore-on-the-abcsg-16-trial\u002F.\n2011, Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet, 378, 771, 10.1016\u002FS0140-6736(11)60993-8\nFisher, 2001, Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 Randomized Trial, JNCI J Natl Cancer Inst, 93, 684, 10.1093\u002Fjnci\u002F93.9.684\nStewart, 2001, Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years, J Natl Cancer Inst, 93, 456, 10.1093\u002Fjnci\u002F93.6.456\nTormey, 1996, Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer, J Natl Cancer Inst, 88, 1828, 10.1093\u002Fjnci\u002F88.24.1828\nDavies, 2013, Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, Lancet, 381, 805, 10.1016\u002FS0140-6736(12)61963-1\nGray, 2013, aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer, J Clin Oncol, 31\nAl-Mubarak, 2014, Extended adjuvant tamoxifen for early breast cancer: a meta-analysis, PLoS ONE, 9, 10.1371\u002Fjournal.pone.0088238\nBartlett, 2019, Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial, Ann Oncol, 30, 1776, 10.1093\u002Fannonc\u002Fmdz289\nPagani, 2020, Absolute improvements in freedom from distant recurrence to Tailor adjuvant endocrine therapies for premenopausal women: results from TEXT and SOFT, J Clin Oncol, 38, 1293, 10.1200\u002FJCO.18.01967\nKorde, 2010, Multidisciplinary meeting on male breast cancer: summary and research recommendations, J Clin Oncol, 28, 2114, 10.1200\u002FJCO.2009.25.5729\nCardoso, 2018, Characterization of male breast cancer: results of the EORTC 10085\u002FTBCRC\u002FBIG\u002FNABCG International Male Breast Cancer Program, Ann Oncol, 29, 405, 10.1093\u002Fannonc\u002Fmdx651\nSousa, 2013, An update on male breast cancer and future directions for research and treatment, Eur J Pharmacol, 717, 71, 10.1016\u002Fj.ejphar.2013.03.037\nEggemann, 2013, Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients, Breast Cancer Res Treat, 137, 465, 10.1007\u002Fs10549-012-2355-3",{"ES":1299},"Tratamiento del cáncer de mama infiltrante localizado: nuevos desafíos",{"VOID":1301},"10.1016\u002Fs1283-081x(21)45718-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X21457188",[1304,1321,1336,1361,1380,1395,1414],{"id":1305,"sortIndex":59,"researcher":26,"roles":1306,"affiliations":1307,"properties":1318},"7bfa269a-ec8d-49b3-bb6b-8801d2a76bf7",[696],[1308],{"id":26,"sortIndex":36,"affiliation":1309,"properties":26},{"id":1310,"createTime":1311,"updateTime":1312,"relativeEntities":1313,"slug":1314,"properties":1315,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"02f55f68-9e66-474d-acc8-74ccef7eb103","2024-01-03T14:07:46.219+00:00","2025-06-11T16:19:54.162+00:00",[],"D%C3%A9partement-de-radioth%C3%A9rapie-Centre-Georges-Fran%C3%A7ois-Leclerc-1-rue-Pr-Marion-21000-Dijon-France",{"title":1316},{"VI":1317},"Département de radiothérapie, Centre Georges François Leclerc, 1, rue Pr Marion, 21000 Dijon, France",{"title":1319},{"VI":1320},"K. Peignaux",{"id":1322,"sortIndex":111,"researcher":26,"roles":1323,"affiliations":1324,"properties":1333},"f02bc45d-23b3-49d7-8a44-3d289fbb36b3",[696],[1325],{"id":26,"sortIndex":36,"affiliation":1326,"properties":26},{"id":1327,"createTime":1328,"updateTime":1328,"relativeEntities":1329,"slug":26,"properties":1330,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a87a1def-e0a5-4bda-99d3-3c58b13a05d8","2024-01-03T14:07:46.228+00:00",[],{"title":1331},{"VI":1332},"Département de biologie et de pathologie des tumeurs, Centre Georges François Leclerc, 1, rue Pr Marion, 21000 Dijon, France",{"title":1334},{"VI":1335},"L. Arnould",{"id":1337,"sortIndex":115,"researcher":26,"roles":1338,"affiliations":1339,"properties":1358},"cedc7ed2-7f52-4873-9100-3c6e2fc9bac6",[696],[1340,1350],{"id":1341,"sortIndex":115,"affiliation":1342,"properties":1349},"866672d3-fe48-488d-ba6c-9b4dc5106f1b",{"id":1343,"createTime":1344,"updateTime":1344,"relativeEntities":1345,"slug":26,"properties":1346,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4fba1af7-1d23-4c64-9dbc-54e5a547d646","2024-01-03T14:07:46.242+00:00",[],{"title":1347},{"VI":1348},"UFR des sciences de santé, 7, boulevard Jeanne d’Arc, 21000 Dijon, France",{},{"id":26,"sortIndex":36,"affiliation":1351,"properties":26},{"id":1352,"createTime":1353,"updateTime":1353,"relativeEntities":1354,"slug":26,"properties":1355,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3299e841-c1e6-4e42-a052-16461bcc4bc6","2024-01-03T14:07:46.180+00:00",[],{"title":1356},{"VI":1357},"Département d’oncologie médicale, Centre Georges François Leclerc, 1, rue Pr Marion, 21000 Dijon, France",{"title":1359},{"VI":1360},"J.-D. Fumet",{"id":1362,"sortIndex":114,"researcher":26,"roles":1363,"affiliations":1364,"properties":1377},"4d5dadb1-bbc4-4c77-9cf5-d96f34550324",[696],[1365,1370],{"id":26,"sortIndex":36,"affiliation":1366,"properties":26},{"id":1352,"createTime":1353,"updateTime":1353,"relativeEntities":1367,"slug":26,"properties":1368,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1369},{"VI":1357},{"id":1371,"sortIndex":115,"affiliation":1372,"properties":1376},"3bc84a86-2e77-48f8-89a2-38b5fc9f77db",{"id":1343,"createTime":1344,"updateTime":1344,"relativeEntities":1373,"slug":26,"properties":1374,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1375},{"VI":1348},{},{"title":1378},{"VI":1379},"C. Kaderbhai",{"id":1381,"sortIndex":36,"researcher":26,"roles":1382,"affiliations":1383,"properties":1392},"5f6354a5-5796-4539-9ac8-19a1eef3f503",[696],[1384],{"id":26,"sortIndex":36,"affiliation":1385,"properties":26},{"id":1386,"createTime":1387,"updateTime":1387,"relativeEntities":1388,"slug":26,"properties":1389,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e19d8151-be85-4534-802b-2629da7c6ace","2024-01-03T14:07:46.254+00:00",[],{"title":1390},{"VI":1391},"Département de chirurgie oncologique, Centre Georges François Leclerc, 1, rue Pr Marion, 21000 Dijon, France",{"title":1393},{"VI":1394},"C. Jankowski",{"id":1396,"sortIndex":162,"researcher":26,"roles":1397,"affiliations":1398,"properties":1411},"bf20e707-ea48-40c1-bdc3-077ca7a31435",[696],[1399,1404],{"id":26,"sortIndex":36,"affiliation":1400,"properties":26},{"id":1352,"createTime":1353,"updateTime":1353,"relativeEntities":1401,"slug":26,"properties":1402,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1403},{"VI":1357},{"id":1405,"sortIndex":115,"affiliation":1406,"properties":1410},"92ba4466-cda0-4e86-be6c-fd691891c471",{"id":1343,"createTime":1344,"updateTime":1344,"relativeEntities":1407,"slug":26,"properties":1408,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1409},{"VI":1348},{},{"title":1412},{"VI":1413},"S. Ladoire",{"id":1415,"sortIndex":135,"researcher":26,"roles":1416,"affiliations":1417,"properties":1430},"a7cfdd9f-f5d4-42a1-b01c-b05d9d11bfda",[696],[1418,1425],{"id":1419,"sortIndex":115,"affiliation":1420,"properties":1424},"fcadd45c-fccf-4729-adb2-141858fadaaa",{"id":1343,"createTime":1344,"updateTime":1344,"relativeEntities":1421,"slug":26,"properties":1422,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1423},{"VI":1348},{},{"id":26,"sortIndex":36,"affiliation":1426,"properties":26},{"id":1386,"createTime":1387,"updateTime":1387,"relativeEntities":1427,"slug":26,"properties":1428,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1429},{"VI":1391},{"title":1431},{"VI":1432},"C. Coutant",{"url":1302,"publisher":1434,"properties":1442},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1435,"slug":662,"properties":1436,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1439,"manageAffiliations":1440,"indexDatabases":1441,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1437,"title":1438},{"VOID":665},{"EN":667},[],[],[],{"volume":1443,"pages":1444},{"VOID":1026},{"VOID":1445},"1-20","2021-10-01",{"id":1448,"createTime":1449,"updateTime":1450,"relativeEntities":1451,"slug":1452,"properties":1453,"entityType":688,"verifyStatus":25,"verifyTime":1450,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1460,"fullTextUrl":26,"authors":1461,"publicationType":747,"publisherRelationship":1588,"citationCount":26,"citationInfo":26,"publishDate":1602,"publishYear":1603,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"685c10b1-ef75-4288-a275-04c7b3e0894d","2024-02-14T04:35:30.152+00:00","2025-01-26T10:48:59.293+00:00",[],"Laparoscopia-y-cirug%C3%ADa-laparosc%C3%B3pica-principios-generales-e-instrumental",{"references":1454,"title":1456,"doi":1458},{"VOID":1455},"Palmer, 1948, La cœlioscopie, Bruxells Med., 28, 305\nBruhat, 1979, Essai d'un traitement per cœlioscopique de la grossesse extra-utérine : à propos de 26 observations, Rev. Fr. Gynecol. Obstet., 72, 667\nReich, 1989, Laparoscopic hysterectomy, J. Gynecol. Surg., 5, 213, 10.1089\u002Fgyn.1989.5.213\nwww.websurg.com.\nBruhat, 1991\nHolzer, 2006, Laparoscopic versus open myomectomy: a double-blind study to evaluate postoperative pain, Anesth. Analg., 102, 1480, 10.1213\u002F01.ane.0000204321.85599.0d\nGarry, 2006, Laparoscopic surgery, Best Pract. Res. Clin. Obstet. Gynecol., 20, 89, 10.1016\u002Fj.bpobgyn.2005.10.003\nGarry, 1997, Complications of laparoscopic entry, Gynecol. Endosc., 6, 319, 10.1111\u002Fj.1365-2508.1997.151-gy0558.x\nQuerleu, 1993, Complications of gynaecological laparoscopic surgery: a French collaborative study, Gynecol. Endosc., 2, 3\nChapron, 1998, Surgical complications of diagnostic and operative gynaecological laparoscopy. A series of 29 966 cases, Hum. Reprod., 13, 867, 10.1093\u002Fhumrep\u002F13.4.867\nMenes, 2000, Laparoscopy: searching for the proper insufflation gas, Surg. Endosc., 14, 1050, 10.1007\u002Fs004640000216\nGutt, 2004, Circulatory and respiratory complications of carbon dioxide insufflation, Dig. Surg., 21, 95, 10.1159\u002F000077038\nElkelani, 2004, Effect of adding more than 3% oxygen to carbon dioxide pneumoperitoneum on adhesion formation in a laparoscopic mouse model, Fertil. Steril., 82, 1616, 10.1016\u002Fj.fertnstert.2004.07.933\nLarsen, 2004, Randomized clinical trial of the effect of pneumoperitoneum on cardiac function and haemodynamics during laparoscopic cholecystectomy, Br. J. Surg., 91, 848, 10.1002\u002Fbjs.4573\nAlijani, 2004, Abdominal wall lift versus positive-pressure capnoperitoneum for laparoscopic cholecystectomy: randomized controlled trial, Ann. Surg., 239, 388, 10.1097\u002F01.sla.0000114226.31773.e3\nNeudecker, 2002, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery, Surg. Endosc., 16, 1121, 10.1007\u002Fs00464-001-9166-7\nMalik, 2000, Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid, Surg. Endosc., 14, 452, 10.1007\u002Fs004640000160\nLöning, 2004, Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX, Cancer, 100, 1650, 10.1002\u002Fcncr.20155\nBuchweitz, 2006, Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy, Am. J. Obstet. Gynecol., 195, 949, 10.1016\u002Fj.ajog.2006.02.044\nKadar, 1993, Incisional hernias after major laparoscopic gynecologic procedures, Am. J. Obstet. Gynecol., 168, 1493, 10.1016\u002FS0002-9378(11)90787-X\nSinghvi, 2002, Assessment of the physical properties of endoscopic retrieval systems, Br. J. Surg., 89, 1183, 10.1046\u002Fj.1365-2168.2002.02192.x\nKöchli, 2000, Endobag extractor to remove masses during laparoscopy, Obstet. Gynecol., 95, 304\nHarold, 2003, Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries, Surg. Endosc., 17, 1228, 10.1007\u002Fs00464-002-8833-7\nDiamantis, 2006, Comparison of monopolar electrocoagulation, bipolar electrocoagulation, ultracision, and ligasure, Surg. Today, 36, 908, 10.1007\u002Fs00595-006-3254-1\nEmam, 2003, How safe is high-power ultrasonic dissection?, Ann. Surg., 237, 186, 10.1097\u002F01.SLA.0000048454.11276.62\nHensman, 1998, Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment: an in-vitro study, Surg. Endosc., 12, 1017, 10.1007\u002Fs004649900771\n2006, Control and prevention of peritoneal adhesions in gynecologic surgery, Fertil. Steril., 86, S1, 10.1016\u002Fj.fertnstert.2006.07.1483\nAit Menguellet, 2007, Interest in agents for adhesion prevention after gynecologic surgery, Gynecol. Obstet. Fertil., 35, 290, 10.1016\u002Fj.gyobfe.2007.02.011\nBrown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, Dizerega GS; on behalf of the Adept Adhesion Reduction Study Group. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil. Steril. 2007; (Mar23;[Epub ahead of print]).",{"ES":1457},"Laparoscopia y cirugía laparoscópica: principios generales e instrumental",{"VOID":1459},"10.1016\u002Fs1283-081x(08)70808-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708087",[1462,1477,1489,1501,1513,1528,1540,1552,1564,1576],{"id":1463,"sortIndex":52,"researcher":26,"roles":1464,"affiliations":1465,"properties":1474},"c8c8b4c6-cad9-47b1-88b4-2fa9709cd311",[696],[1466],{"id":26,"sortIndex":36,"affiliation":1467,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1470,"slug":26,"properties":1471,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"85222ac4-6572-4fda-bf7c-ff8b8443aea4","2024-02-14T04:35:30.184+00:00",[],{"title":1472},{"VI":1473},"Centre hospitalier universitaire de Clermont-Ferrand, Polyclinique de l'Hôtel-Dieu, service de gynécologie obstétrique et médecine de la reproduction, boulevard Léon-Malfreyt, 63000 Clermont-Ferrand, France",{"title":1475},{"VI":1476},"M. Canis",{"id":1478,"sortIndex":162,"researcher":26,"roles":1479,"affiliations":1480,"properties":1486},"a58dd99f-be9e-4f4c-be9a-25dc0e5d3625",[696],[1481],{"id":26,"sortIndex":36,"affiliation":1482,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1483,"slug":26,"properties":1484,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1485},{"VI":1473},{"title":1487},{"VI":1488},"B. Rabischong",{"id":1490,"sortIndex":115,"researcher":26,"roles":1491,"affiliations":1492,"properties":1498},"87b8574f-629e-448c-8dd5-2c74efe52dd4",[696],[1493],{"id":26,"sortIndex":36,"affiliation":1494,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1495,"slug":26,"properties":1496,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1497},{"VI":1473},{"title":1499},{"VI":1500},"L. Velemir",{"id":1502,"sortIndex":158,"researcher":26,"roles":1503,"affiliations":1504,"properties":1510},"aa307ae0-1c39-41bf-9b5d-d85b078d85f5",[696],[1505],{"id":26,"sortIndex":36,"affiliation":1506,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1507,"slug":26,"properties":1508,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1509},{"VI":1473},{"title":1511},{"VI":1512},"J.-L. Pouly",{"id":1514,"sortIndex":114,"researcher":26,"roles":1515,"affiliations":1516,"properties":1525},"f9e4efa3-0037-48b4-ac7f-412129e460e9",[696],[1517],{"id":26,"sortIndex":36,"affiliation":1518,"properties":26},{"id":1519,"createTime":1520,"updateTime":1520,"relativeEntities":1521,"slug":26,"properties":1522,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b293de01-17b5-4cbf-ba79-716d1d09c39d","2024-02-14T04:35:30.198+00:00",[],{"title":1523},{"VI":1524},"Centre hospitalier universitaire de Strasbourg, service de gynécologie-obstétrique, 1, place de l'Hôpital, 67000 Strasbourg cedex, France",{"title":1526},{"VI":1527},"A. Wattiez",{"id":1529,"sortIndex":50,"researcher":26,"roles":1530,"affiliations":1531,"properties":1537},"59add75c-c97b-4abc-abff-ded75ae3ae12",[696],[1532],{"id":26,"sortIndex":36,"affiliation":1533,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1534,"slug":26,"properties":1535,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1536},{"VI":1473},{"title":1538},{"VI":1539},"G. Mage",{"id":1541,"sortIndex":111,"researcher":26,"roles":1542,"affiliations":1543,"properties":1549},"f8509d99-5fd4-480b-9475-73f76ed302c4",[696],[1544],{"id":26,"sortIndex":36,"affiliation":1545,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1546,"slug":26,"properties":1547,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1548},{"VI":1473},{"title":1550},{"VI":1551},"F. Bolandard",{"id":1553,"sortIndex":36,"researcher":26,"roles":1554,"affiliations":1555,"properties":1561},"146c4216-24f6-4d94-8f77-0d3dc19e95ff",[696],[1556],{"id":26,"sortIndex":36,"affiliation":1557,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1558,"slug":26,"properties":1559,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1560},{"VI":1473},{"title":1562},{"VI":1563},"R. Botchorishvili",{"id":1565,"sortIndex":59,"researcher":26,"roles":1566,"affiliations":1567,"properties":1573},"f1fab820-877b-401f-b071-e34df3023ec3",[696],[1568],{"id":26,"sortIndex":36,"affiliation":1569,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1570,"slug":26,"properties":1571,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1572},{"VI":1473},{"title":1574},{"VI":1575},"X. Tran",{"id":1577,"sortIndex":135,"researcher":26,"roles":1578,"affiliations":1579,"properties":1585},"e93b2b92-376f-4527-b159-2edb6a808f2a",[696],[1580],{"id":26,"sortIndex":36,"affiliation":1581,"properties":26},{"id":1468,"createTime":1469,"updateTime":1469,"relativeEntities":1582,"slug":26,"properties":1583,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1584},{"VI":1473},{"title":1586},{"VI":1587},"K. Jardon",{"url":1460,"publisher":1589,"properties":1597},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1590,"slug":662,"properties":1591,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1594,"manageAffiliations":1595,"indexDatabases":1596,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1592,"title":1593},{"VOID":665},{"EN":667},[],[],[],{"volume":1598,"pages":1600},{"VOID":1599},"44",{"VOID":1601},"1-15","2008-01-01",2008,{"id":1605,"createTime":1606,"updateTime":1607,"relativeEntities":1608,"slug":1609,"properties":1610,"entityType":688,"verifyStatus":25,"verifyTime":1617,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1618,"fullTextUrl":26,"authors":1619,"publicationType":747,"publisherRelationship":1671,"citationCount":26,"citationInfo":26,"publishDate":1229,"publishYear":1230,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"c425188b-3337-4921-9c93-f85aaf8b2e78","2023-12-13T11:01:29.884+00:00","2025-01-16T19:05:00.183+00:00",[],"Listeriosis-en-el-embarazo",{"references":1611,"title":1613,"doi":1615},{"VOID":1612},"2000\nBenhaim, 2003, Intérêt de l'amniocentèse dans le diagnostic et la prise en charge d'une chorioamiotite à Listeria monocytogenes, J Gynécol Obstet Biol Reprod, 32, 396\n2000, Avis sur l'opportunité d'une antibioprophylaxie pour les personnes ayant consommé un aliment contaminé par Listeria monocytogenes, Bull Epidémiol Hebd, n°4\nCraig, 1996, Perinatal infection with Listeria monocytogenes, Aust NZ J Obstet Gynaecol, 36, 286, 10.1111\u002Fj.1479-828X.1996.tb02712.x\nFrederiksen, 1992, Feto-maternal listeriosis in Denmark 1981-1988, J Infect, 24, 277, 10.1016\u002FS0163-4453(05)80033-7\nGellin, 1989, Listeriosis, JAMA, 261, 1313, 10.1001\u002Fjama.1989.03420090077035\nGianfranceschi, 2003, Incidence of Listeria monocytogenes in food and environmental samples in Italy between 1990 and 1999: serotype distribution in food, environmental and clinical samples, Eur J Epidemiol, 18, 1001, 10.1023\u002FA:1025849532417\nGholizadeh, 1996, Serodiagnosis of listeriosis based upon detection of antibodies against recombinant truncated forms of listeriolysin O, J Clin Microbiol, 34, 1391, 10.1128\u002FJCM.34.6.1391-1395.1996\nGombas, 2003, Survey of Listeria monocytogenes in ready-to-eat foods, J Food Prot, 66, 559, 10.4315\u002F0362-028X-66.4.559\nGoulet, 1996, Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions, Scand J Infect Dis, 28, 367, 10.3109\u002F00365549609037921\nGoulet, 2001, Effect of prevention measures on incidence of human listeriosis, France, 1987-1997, Emerg Infect Dis, 7, 983, 10.3201\u002Feid0706.010610\nGoulet, 2001, La surveillance de la listériose humaine en France en 1999, Bull Epidémiol Hebd\nGray, 1993, Faecal carriage of Listeria during pregnancy, Br J Obstet Gynaecol, 100, 873, 10.1111\u002Fj.1471-0528.1993.tb14324.x\nGrif, 2001, Prevalence and characterization of Listeria monocytogenes in the feces of healthy Austrians, Wien Klin Wochenschr, 113, 737\nGrif, 2003, Incidence of fecal carriage of Listeria monocytogenes in three healthy volunteers: a one-year prospective stool survey, Eur J Clin Microbiol Infect Dis, 22, 16, 10.1007\u002Fs10096-002-0835-9\nHjaltested, 2002, Listeriosis in Iceland, 1978-2000: a description of cases and molecular epidemiology, Scand J Infect Dis, 34, 735, 10.1080\u002F0036554021000026925\nHof, 2003, History and epidemiology of listeriosis, FEMS Immunol Med Microbiol, 35, 199, 10.1016\u002FS0928-8244(02)00471-6\nJacquet, 1999, La listériose humaine en France en 1998, Bull Épidémiol Hebd, n°37\nJensen, 1994, Risk factors for listeriosis in Denmark, 1989-1990, Scand J Infect Dis, 26, 171, 10.3109\u002F00365549409011781\nJones, 1995, Antimicrobial chemotherapie of human infection due to Listeria monocytogenes, Eur J Clin Microbiol Infect Dis, 14, 165, 10.1007\u002FBF02310351\nKampelmacher, 1972, The presence of Listeria monocytogenes in feces of pregnant women and neonates, Zentrabl Bacteriol, 222, 258\nLukinmaa, 2003, Listeria monocytogenes isolates from invasive infections: variation of sero- and genotypes during an 11-year period in Finland, J Clin Microbiol, 41, 1694, 10.1128\u002FJCM.41.4.1694-1700.2003\nMcLauchlin, 1990, Human listeriosis in Britain, 1967-85, a summary of 722 cases. 1. Listeriosis during pregnancy and in the newborn, Epidemiol Infect, 104, 181, 10.1017\u002FS0950268800059343\nMylonakis, 1998, Central nervous system infection with Listeria monocytogenes. 33 years'experience at a general hospital and review of 776 episodes from the literature, Medicine, 77, 313, 10.1097\u002F00005792-199809000-00002\nMylonakis, 2002, Listeriosis during pregnancy: a case series and review of 222 cases, Medicine, 81, 260, 10.1097\u002F00005792-200207000-00002\nNolla-Salas, 1998, Perinatal listeriosis: a population-based multicenter study in Barcelona, Spain (1990-1996), Am J Perinatol, 15, 461, 10.1055\u002Fs-2007-994067\nRouquette, 1996, The pathogenesis of infection by Listeria monocytogenes, Microbiologia, 12, 245\nSafdar, 2003, Listeriosis in patients at a comprehensive cancer center, 1955-1997, Clin Infect Dis, 37, 359, 10.1086\u002F376631\nSchlech, 1996, Pathogenesis and immunology of Listeria monocytogenes, Pathol Biol, 44, 775\nSiegman-Igra, 2002, Listeria monocytogenes infection in Israel and review of cases worldwide, Emerg Infect Dis, 8, 305, 10.3201\u002Feid0803.010195\nSilver, 1998, Listeriosis during pregnancy, Obstet Gynecol Surv, 53, 737, 10.1097\u002F00006254-199812000-00004\nSmerdon, 2001, Surveillance of listeriosis in England and Wales, 1995-1999, Commun Dis Public Health, 4, 188",{"ES":1614},"Listeriosis en el embarazo",{"VOID":1616},"10.1016\u002Fs1283-081x(05)70237-x","2025-01-16T19:05:00.182+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X0570237X",[1620,1635,1647,1659],{"id":1621,"sortIndex":59,"researcher":26,"roles":1622,"affiliations":1623,"properties":1632},"a90adecb-5732-4c14-b474-50ccc6ce61e8",[696],[1624],{"id":26,"sortIndex":36,"affiliation":1625,"properties":26},{"id":1626,"createTime":1627,"updateTime":1627,"relativeEntities":1628,"slug":26,"properties":1629,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"158b3d72-b95e-4ba0-939b-7e8d7b6c51b7","2023-12-13T11:01:29.945+00:00",[],{"title":1630},{"VI":1631},"Institut Mère-Enfant Alix de Champagne, Centre hospitalier universitaire, 51092 Reims cedex, France",{"title":1633},{"VI":1634},"R. Gabriel",{"id":1636,"sortIndex":36,"researcher":26,"roles":1637,"affiliations":1638,"properties":1644},"01f4f855-63c9-468d-88c4-061fc52e08c4",[696],[1639],{"id":26,"sortIndex":36,"affiliation":1640,"properties":26},{"id":1626,"createTime":1627,"updateTime":1627,"relativeEntities":1641,"slug":26,"properties":1642,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1643},{"VI":1631},{"title":1645},{"VI":1646},"S. Deguelte",{"id":1648,"sortIndex":114,"researcher":26,"roles":1649,"affiliations":1650,"properties":1656},"c8a7267c-5c96-4502-8d38-1cab55b285c3",[696],[1651],{"id":26,"sortIndex":36,"affiliation":1652,"properties":26},{"id":1626,"createTime":1627,"updateTime":1627,"relativeEntities":1653,"slug":26,"properties":1654,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1655},{"VI":1631},{"title":1657},{"VI":1658},"C. Quereux",{"id":1660,"sortIndex":115,"researcher":26,"roles":1661,"affiliations":1662,"properties":1668},"8e7dd7ee-d385-4ed3-b74a-32aeca8061ba",[696],[1663],{"id":26,"sortIndex":36,"affiliation":1664,"properties":26},{"id":1626,"createTime":1627,"updateTime":1627,"relativeEntities":1665,"slug":26,"properties":1666,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1667},{"VI":1631},{"title":1669},{"VI":1670},"M.-P. Metge",{"url":1618,"publisher":1672,"properties":1680},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1673,"slug":662,"properties":1674,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1677,"manageAffiliations":1678,"indexDatabases":1679,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1675,"title":1676},{"VOID":665},{"EN":667},[],[],[],{"volume":1681,"pages":1682},{"VOID":1226},{"VOID":1683},"1-5"]